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THE KINETOCHORE PROTEIN KNL1 LINKS KINETOCHORE-MICROTUBULE 
ATTACHMENT AND CHEKPOINT SIGNALING DURING MITOSIS  
 
Mitosis is the phase of the cell cycle in which replicated chromosomes physically 
separate, resulting in the formation of two genetically identical daughter cells. This process is not 
only essential for the development of a single fertilized cell into a multicellular organism, but 
also for replacement of damaged and dying cells during the span life of an organism.  
The distribution of chromosomes during mitotic cell division requires accurate yet 
dynamic attachment between the plus-ends of spindle microtubules (MTs) and kinetochores, 
which are protein structures assembled at the centromeric region of replicated chromatids. The 
tightly regulated connection between kinetochores and MTs allows for chromosome congression 
to the metaphase plate and subsequent separation of the replicated chromosomes during 
anaphase. Not surprisingly, the inability of cells to resolve erroneous kinetochore-MT 
attachments results in missegregation of chromosomes, which is linked to uncontrolled cell 
proliferation and cancer. Thus, proper kinetochore-MT attachment during cell division is 
essential for the maintenance of genetic integrity. 
Despite a growing understanding of the identity of proteins that compose the kinetochore 
and the processes for which they are required, the precise functions of many kinetochore proteins 
are still unknown. KNL1, a large kinetochore scaffolding protein, contributes to several signaling 
pathways coordinated by the kinetochore. Yet, how KNL1 recruits its various binding partners to 
the kinetochore, and whether KNL1 directly or indirectly modulates protein function during 
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mitosis are unresolved questions. In this dissertation, I examine the function of KNL1 in the 
regulation of kinetochore-MT attachment and determine the regions of KNL1 required for the 
accumulation of an array of kinetochore proteins. By loss of function analyses using a set of 
KNL1 mutants, combined with functional assays in cells, I demonstrate that the KNL1 N-
terminus is essential for Aurora B kinase activity at kinetochores and for correct kinetochore-MT 
dynamics. Aurora B kinase phosphorylates kinetochore proteins during early mitosis, increasing 
kinetochore–microtubule (MT) turnover and preventing premature stabilization of kinetochore–
MT attachments. Therefore, KNL1 is required for correct Aurora B-mediated kinetochore-MT 
attachment regulation during mitosis. I provide evidence that the KNL1 N-terminus influences 
Aurora B activity by mediating the activity of Bub1 kinase, a kinetochore protein required for the 
spindle assembly checkpoint (SAC). The SAC mediates amplification of an inhibitory signal to 
prevent mitotic exit until all chromosomes are correctly attached to MTs. Although the SAC is 
known to be tightly coupled to kinetochore-MT attachment, how such coupling occurs at the 
kinetochore is a major unanswered question. The finding that KNL1 mediates Aurora B activity 
through Bub1 establishes KNL1 as a key integrator of multiple signaling pathways at the 
kinetochore. Finally, I determine the regions of KNL1 required for the accumulation of several 
kinetochore proteins, providing a broad view and better understanding of kinetochore 
organization inside the cell. Overall, results from these studies establish KNL1 as a central 
organizer of kinetochore architecture and function, and demonstrate the direct influence of this 
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1.1 The kinetochore and its role during mitosis 
During mitosis, replicated chromosomes attach to spindle microtubules (MTs) in order to 
congress to the spindle equator and correctly segregate to opposite spindle poles during 
anaphase. Attachment between replicated chromosomes and MTs is mediated by the 
kinetochore, a complex network of proteins assembled on centromeric DNA of each mitotic 
sister chromatid. The kinetochore also orchestrates a sophisticated signaling network called the 
spindle assembly checkpoint (SAC), a fail-safe mechanism that prevents mitotic exit until all 
chromosomes are attached to spindle MTs. Kinetochores are comprised of over 100 proteins, 
many of which are evolutionarily conserved and exhibit high interdependency and functionally 
diverse roles [1-3]. Despite this complexity, we are beginning to understand the molecular basis 
for kinetochore assembly [1,3], chromosome congression [4-6], and SAC signaling [7-9].  
 
 
This chapter, presented as an introduction to my doctoral work, was published as a review article in 2013 
under the title “KNL1: bringing order to the kinetochore”; the full reference appears below.  Modifications to the 
published version have been made and, for simplicity, some sections contained in the published manuscript are not 
presented here. Some figures shown in this chapter are not included in the published review article. 
 
J.G.D and I conceived the content of this review. I wrote the manuscript with input from J.G.D.  
 





The scaffold protein KNL1, a relatively recently described kinetochore protein, plays an 
important role in these critical mitotic processes, however, its specific contributions to each are 
just beginning to be appreciated. Here, I provide an overview of the current state of 
understanding of KNL1, a protein that is emerging as a key integrator of multiple kinetochore 
activities. 
 
1.2 KNL1: the unknown structure 
KNL1 is an evolutionarily conserved kinetochore-associated protein essential for 
accurate chromosome segregation in eukaryotic cells. In human cells, KNL1 was first recognized 
as a kinetochore protein in 2004, and its conserved role in kinetochore assembly was later 
demonstrated [10-13]. Since its discovery, KNL1 has been known as a critical platform for 
kinetochore protein recruitment and as a linker between centromeric DNA and the plus-ends of 
spindle MTs, not only in human cells but also in yeast, chicken, and flies [11, 14-17].  
Despite being evolutionarily conserved, KNL1 displays low overall sequence similarity 
between species, and according to folding prediction algorithms, it is mostly intrinsically 
disordered (FoldIndex, Phyre) (Figure 1.2). In human KNL1 for example, with over 2300 amino 
acids, less than half of the protein is predicted to fold into an ordered structure. Most of this 
ordered structure resides at the far C-terminus of the protein, and it is composed of a globular 
domain containing tandem RWD motifs [18] and a coiled-coil domain [19]. The RWD motifs 
mediate direct interaction with the Mis12 complex, while the coiled-coil domain mediates 
interaction with Zwint-1. Both Mis12 and Zwint-1 are proteins important for proper kinetochore 
assembly (Figure 1.3). Within the remaining “unstructured” region of the protein, several motifs 
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have been identified. The RVSF (RVXF) and SILK ([SG]ILK) motifs, both of which  reside at 
the far N-terminus of KNL1, mediate binding of the phosphatase PP1 [20]. Two KI motifs, KI1 
and KI2 (KI[DN]XXXF[LI]XXLK), also localized in the N-terminus of KNL1, interact with the 
essential SAC proteins Bub1 and BubR1, respectively [13, 21, 22] (Figure 1.3). More recently, 
MELT motifs (M[ED][ILVM][ST]) in the N-terminal and central regions of KNL1 have been 
identified and demonstrated as mediators for recruitment of Bub1 and Bub3, another essential 
SAC component [23-26] (Figure 1.3). A search for KNL1 orthologs across eukaryotes recently 
identified KNL1 in three out of all six eukaryotic supergroups [27]. Although KNL1 primary 
sequence similarity across species is poor and the predicted protein size is quite variable, the C-
terminal region, SILK, RVSF, and MELT motifs are well conserved. The number of MELT 
motifs across species, however, is widely variable [27] (Figure 1.4). 
Full-length C. elegans KNL1 and fragments of yeast and human KNL1 have been 
successfully reconstituted in vitro [21, 22, 25, 26, 28, 29]. However, there is a dearth of 
structural information for KNL1, as only small fragments of the human N-terminal region 
containing the KI motifs [21, 22], and small fragments of yeast KNL1 (Spc105) containing 
MELT motifs have been crystallized [24] (Figure 1.5). In these atomic structures only a handful 
of residues (~15) showed significant electron density, presumably due to the disordered nature of 
KNL1. The residues identified with confidence in the structures of both KNL1 KI motifs fold 
into short alpha-helices when bound to Bub1 or BubR1 [21, 22]. Circular dichroism experiments 
indicate that these regions of KNL1 by themselves lack secondary structure [21], thus it appears 





1.3 KNL1 and the KMN network 
   KNL1 is a component of the “KMN network,” a complex of proteins that makes up the 
primary MT binding interface at the kinetochore. The KMN network is comprised of the KNL1 
protein, the Mis12 complex (Mis12, Dsn1, Nsl1, and Nnf1) and the Ndc80 complex (Hec1, 
Nuf2, Spc24, and Spc25) [30-32] (Figure 1.6). The high binding affinity measured in vitro 
between several KMN components (Kd~nM range) [19], their apparent cooperative binding to 
MTs [28] and their substantial co-dependency for kinetochore recruitment in vivo [32] (Figure 
1.7), suggest that these proteins function together during mitosis. The most recognized function 
of the KMN network at kinetochores is linkage of the inner kinetochore (chromatin-proximal 
region) to plus-ends of spindle MTs. Association with the inner kinetochore region requires 
binding between the Mis12 complex and the CCAN (Constitutive Centromere Associated 
Network), a large group of centromere-associated proteins responsible for establishing and 
maintaining centromere identity [33] (Figure 1.1). The KMN-MT interaction on the other hand, 
is primarily mediated by Hec1, a component of the Ndc80 complex [28, 34-37]. KNL1 also 
directly binds MTs in vitro, however, a significant role for this MT-binding activity in the 
formation of end-on, force-generating kinetochore-MT attachments has not been demonstrated. 
Although the KMN network is considered a functional unit [28], it is important to note that 
depletion of individual KMN components results in different phenotypes. For instance, Mis12 
and KNL1 depletion from human cells leads to a partial chromosome alignment phenotype [11, 
38, 39], while depletion of any of the Ndc80 complex subunits leads to severe kinetochore-MT 
attachment defects and completely unaligned chromosomes [31]. To what extent the components 
of the KMN network rely on each other to carry out their functions, independent of their role in 
network connectivity, is an interesting question for further study. 
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1.4 KNL1 in kinetochore assembly 
In C. elegans, depletion of KNL1 by RNAi results in loss of kinetochore-localized Hec1 
(CeNdc80), Nuf2 (HIM10), Spc25 (KBP3), Bub1, CENP-F (HCP-1), CLASP2, and reduced 
kinetochore localization of Dsn1 (KNL3) and Mis12 [10, 40]. Of those tested, total protein levels 
were maintained in KNL1-depleted embryos, indicating that KNL1 is required for their 
recruitment and/or maintenance at kinetochores but not for their stability [10, 40]. In addition, 
Zwilch (ZWL-1, a component of the RZZ complex which additionally contains ZW10 and Rod), 
Spindly (SPDL-1), and PP1 kinetochore localization is also dependent on KNL1 in C. elegans 
[29, 41].  
Depletion of KNL1 from human cells results in a similar loss of kinetochore proteins as 
observed in C. elegans, with some variations (Figure 1.7). Bub1, Zwint-1 and RZZ components 
are lost from kinetochores in KNL1-depleted cells [11, 12, 42]. BubR1, Cenp-E, Cenp-F, Mad1, 
and Mad2 kinetochore localization rely on Bub1 [43]. Therefore, logic dictates that depletion of 
KNL1 correspondingly results in kinetochore delocalization of Bub1 downstream targets. Not 
surprisingly, BubR1, Cenp-F and Mad2 kinetochore localization is decreased in KNL1-depleted 
cells [11, 12, 39], and we observe a reduction of kinetochore-associated Cenp-E upon KNL1 
depletion from human cells (G.C. and J.D., unpublished data). Presumably, although untested, 
kinetochore recruitment of the dynein-dynactin complex, which depends on the RZZ complex, is 
also perturbed after KNL1 depletion.   
Kinetochore levels of the Mis12 complex component Dsn1 are reduced after KNL1 
depletion from human cells [11]. An early study reported that depletion of KNL1 from DT40 
chicken cells resulted in a 45% reduction of Hec1 at kinetochores, but in human cells Hec1 
localization was not affected [11].  In contrast, a recent study found that Hec1 levels decreased 
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by ~40% after KNL1 depletion in HeLa cells [44]. Despite the disparity, it is evident that the 
Ndc80 complex retains some ability to localize to kinetochores in KNL1-depleted human cells. 
This is not surprising, as it has been demonstrated that the CCAN component CENP-T also 
contributes to kinetochore recruitment of the Ndc80 complex in human cells [45]. Such KNL1-
independent Hec1 kinetochore localization does not follow a pattern through evolution, since as 
in C. elegans, Hec1 relies on KNL1 for localization in Drosophila [17, 40], but this dependency 
is not observed in fission yeast [46].  
 
1.5 KNL1 in SAC activation 
KNL1 serves as a binding platform, both directly and indirectly, for proteins involved in 
the SAC (Spindle Assembly Checkpoint), the safety mechanism that prevents mitotic exit until 
all kinetochores are correctly attached to spindle MTs (Figure 1.6). The SAC delays anaphase by 
promoting and sustaining inhibition of the anaphase promoting complex/cyclosome (APC/C), an 
E3 ubiquitin ligase that, upon activation by Cdc20, targets securin and cyclin B for degradation, 
which ultimately drives mitotic exit [7, 8, 47] (Figure 1.6). The core components of the SAC are 
the evolutionarily conserved proteins Bub1, BubR1/Mad3, Bub3, Mad1, Mad2, and Mps1. All of 
these SAC components, except for Mps1, have been shown to rely on KNL1 for kinetochore 
localization (Figure 1.7). Bub1, Bub3, and BubR1 directly interact with KNL1 [21, 22, 24-26, 
48] (Figure 1.3). Mad1 and Mad2 kinetochore localization depends on Bub1 [49-51] and the 
RZZ complex [52] (Figure 1.7); therefore, it is expected that KNL1 depletion compromises 
Mad1 and Mad2 kinetochore localization [39]. 
KNL1 was first found to associate with Bub1 and BubR1 through yeast two-hybrid 
experiments [12, 13]. Later experiments demonstrated that the two closely related but distinct KI 
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motifs in KNL1, KI1 and KI2, directly bind the TPR (tetratricopeptide repeat) domains of Bub1 
and BubR1, respectively [13, 21, 22]. Interestingly, the KI/TPR interactions are dispensable for 
both Bub1 and BubR1 kinetochore targeting in human cells [22]. However, that is not the case in 
fission yeast, where a ΔTPR Bub1 mutant does not efficiently target to kinetochores [53]. It is 
possible that in human cells, the KI/TPR interaction enhances, but is not essential for SAC 
protein recruitment and/or function. Recent studies in yeast and human cells established that 
Mps1-mediated phosphorylation of the KNL1 MELT repeats is required for Bub1/Bub3 
kinetochore targeting [23-26]. Although Bub1 and Bub3 require each other for KNL1-mediated 
kinetochore localization, the inter-dependency of BubR1 with Bub1 and/or Bub3 for kinetochore 
localization and function remains unresolved. In addition, whether all MELT repeats, specific 
repeats, or a threshold number of repeats are critical for recruiting Bub1 and Bub3 and if MELT 
phosphorylation also mediates direct BubR1 recruitment are outstanding, unanswered questions. 
KNL1 also plays a role in recruiting the essential SAC proteins Mad1 and Mad2 to 
kinetochores, likely through indirect pathways. Mad1, the kinetochore receptor for Mad2, 
requires both Bub1 and the RZZ complex for kinetochore localization [54]. Unattached 
kinetochores accumulate complexes of Mad1–Mad2 that catalyze the conversion of inactive, 
cytoplasmic Mad2 (“open” Mad2) to a form of Mad2 that binds Cdc20 (“closed” Mad2) and 
inhibits APC/C activity [9]. Cdc20-bound Mad2, at the kinetochore or in the cytoplasm, also 
potentially mediates Mad2 catalytic conversion, resulting in further inhibition of APC/CCdc20. 
Mad2-based amplification of the APC/CCdc20 inhibitor is thought to be critical for delaying 
mitotic exit in the presence of unattached kinetochores [55-59]. Although it is clear that Mad1 
and Mad2 are indispensable for SAC function, whether their kinetochore localization is 
explicitly required is not yet resolved [2, 47]. 
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While we are closer to understanding how the checkpoint proteins interact with KNL1, 
how these interactions impact their function in SAC signaling is a fundamental issue that remains 
to be addressed.  
 
1.6 KNL1 in SAC silencing 
The RVSF and SILK motifs in the KNL1 N-terminus mediate direct binding to PP1 
(Figure 1.3), a phosphatase that counteracts Aurora B kinase activity [60]. Aurora B kinase itself 
regulates the interaction between KNL1 and PP1 as binding is disrupted by Aurora B-mediated 
phosphorylation of the RVSF motif [20]. In human cells, PP1 binding to KNL1, together with 
KNL1-BubR1-mediated PP2A kinetochore recruitment, is proposed as a mechanism by which 
outer kinetochore substrates are dephosphorylated during late mitosis, allowing stabilization of 
kinetochore–MT attachments [20, 61, 62]. Interestingly, in both budding and fission yeast and in 
C. elegans , KNL1-mediated PP1 binding contributes to checkpoint silencing [29, 63-66], the 
mechanism that allows APC/Cdc20-mediated mitotic exit.  
The MT binding region of KNL1 is also necessary for SAC silencing in C. elegans 
(Figure 1.3) [29]. Embryos containing mutations in the MT binding domain of KNL1 that 
disrupted MT interaction in vitro were able to congress chromosomes to the metaphase plate 
without obvious kinetochore–MT attachment defects but exhibited delayed anaphase onset [29]. 
It remains to be tested if PP1 binding and/or MT binding activities are crucial for SAC silencing 
in human cells. Experimental manipulation of KNL1, which acts as both a platform for SAC-
activating and SAC-silencing proteins, will help elucidate how checkpoint activation and 
amplification are coupled with checkpoint silencing and how MT attachment modulates this 
complex kinetochore machinery. 
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1.7 Thesis rationale 
The success of mitosis relies on the (1) formation of kinetochore–MT attachments able to 
facilitate both correct congression and segregation of all replicated chromosomes and (2) 
production of a temporally controlled, SAC-generated APC/CCdc20 inhibitor that prevents 
mitotic exit until all chromosomes are properly attached to spindle MTs. Despite considerable 
progress in the understanding of key proteins and molecular mechanisms involved in these two 
processes, there is no unified view of how they are linked. KNL1 is necessary for the 
establishment of a reliable kinetochore–MT interface that attaches dynamic spindle MT plus-
ends to mitotic chromosomes. KNL1 also ensures that SAC proteins required to inhibit 
APC/CCdc20 accumulate at unattached kinetochores to amplify the inhibitory signal and delay 
mitotic exit when appropriate. Moreover, KNL1 is required to quench APC/CCdc20 inhibition 
and silence the SAC to promote mitotic exit when the cell is ready to divide. How KNL1 
contributes to the organization of kinetochore proteins and their interactivity, and how this large 
and mostly “unstructured” protein mediates the coupling of these fundamental mitotic processes 
is the focus of my thesis work.  
In Chapter 2 I demonstrate that the N-terminal region of KNL1 is required for Aurora B 
and Bub1 kinase activities at kinetochores. Aurora B phosphorylates kinetochore proteins during 
early mitosis, increasing kinetochore–MT turnover and preventing premature stabilization of 
kinetochore–MT attachments, which can be detrimental to mitotic progression. Bub1 on the 
other hand, is necessary for the recruitment of checkpoint proteins to kinetochores to ensure 
amplification of the signal that delays mitosis exit when MT attachment is incorrect. Although 
Bub1 has been implicated in the pathway that drives accumulation of Aurora B at the inner 
centromere region, and accumulation of Aurora B at this location is thought to be a requirement 
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for full Aurora B activity, I provide evidence that Aurora B accumulation is not sufficient to 
reach full levels of kinase activity in the absence of KNL1. Based on these findings, I propose a 
mechanism to explain how Aurora B activity is modulated during mitotic progression through 
Bub1/KNL1 and how Aurora B-mediated correction of erroneous kinetochore-MT attachments is 
linked to checkpoint signaling. Importantly, these results raise the possibility that KNL1, 
functioning beyond a kinetochore scaffolding molecule, may play a more direct role, not only in 
the regulation, but also in the coupling of essential mitotic processes. Accordingly, several 
questions come to light. Which proteins are spatially organized by KNL1? What regions or 
motifs on KNL1 are necessary for the localization of these kinetochore proteins? Do these 
proteins compete for the same binding sites on KNL1? Is there interdependency between them? 
How does KNL1 influence the activities of kinetochore proteins? Is KNL1-dependent 
kinetochore organization temporally regulated during mitosis? In Chapter 3, I attempt to address 
some of these questions by systematically mapping kinetochore proteins on different regions of 
KNL1. Although further experiments are required for publication of this work, results from these 
analyses highlight key aspects regarding dependencies and organization of the kinetochore 
network with KNL1 as a central player, and they exemplify the use of KNL1 as a tool to dissect 
kinetochore signaling pathways and kinetochore architecture.      
Figure 1.1. The kinetochore-MT interface. The inner and outer layers/plates of the kinetochore and
the inner centromere region are depicted. Some of the most representative proteins of each layer are
listed. Figure adapted fromMolecular Cell Biology, 3rd ed. [67] and Maiato et al. 2004 [68].
11
Figure 1.2. Human KNL1 Fold Index prediction (http://bip.weizmann.ac.il/fldbin/findex). The
predicted unfolded segments of the protein are shown in red. The sequence is shown below.
12
Figure 1.3. Domain architecture of human KNL1. Key regions involved in KNL1 function are
indicated schematically (top), and the corresponding amino acid sequences for each region in human
KNL1 are listed (bottom). Aurora B kinase phosphorylates the N-terminus of KNL1 to inhibit
association with PP1 (Liu et al. 2010) [20]. Mps1 phosphorylates the KNL1 MELT repeats to promote
association with Bub1 and Bub3 (London et al. 2012; Primorac et al. 2013; Shepperd et al. 2012;
Yamagishi et al. 2012) [23-26]. Amino acid residues 1-68 indicate the MT binding domain (Welburn
et al. 2010) [69], and underlined is a basic patch of residues (RRRH), whose analogous residues in C.
elegans have been implicated in direct MT interaction (Espeut et al. 2012) [29]. Figure adapted from
Caldas and DeLuca 2013 [44].
13
Figure 1.4. Evolutionary conservation of KNL1 domain architecture. Key KNL1 functional
regions are shown for several organisms. The number of amino acids in KNL1 for the various
organisms are shown (right). Two values in this column indicate multiple isoforms (H. sapiens). The
green region in D. melanogaster indicates the presence of repetitive motifs that differ from the MELT
consensus motif observed in other organisms (Schittenhelm et al. 2009) [17]. Figure adapted from
Caldas and DeLuca 2013 [44].
14
Figure 1.5. KNL1 crystal structures. (A) Crystal structure of the TPR domain of hBUBR1 (orange)
in complex with the KI2 motif of hKNL1 (white) (adapted from Bolanos-Garcia et al. 2011) [21].
Hydrophobic residues key for this interaction are depicted in red. A close up image shows that residues
I213, F215, F218 and I219 of KNL1-KI2 bind a shallow hydrophobic groove on BubR1-TPR. The
amino acid sequence of KNL1-KI2 in different species is also shown. (B) Crystal structure of ScBub1
(amino acids 289–359) (yellow), in complex with ScBub3 (green), and a phosphorylated MELT motif
from ScSpc105 (KNL1) (red) (adapted from Primorac et al. 2013) [24]. Side view of the ternary




Figure 1.6. Representation of the principal kinetochore components involved in kinetochore-MT
attachment and checkpoint signaling . (A). The KMN network, required for correct kinetochore-MT
attachment and formed by KNL1, the Mis12 complex, and the Ndc80 complex, is depicted. The
subunits that compose the Mis12 complex and the Ndc80 complex are listed. (B) Current model for
checkpoint signaling. In early mitosis, when unstable kinetochore-MT attachments are present, the
proteins BubR1, Bub3, and Mad2 inhibit Cdc20, the APC activator. Mad2 accumulation at kinetochores
is required for Cdc20 inhibition. In late mitosis, upon stabilization of kinetochore-MT attachments, the
checkpoint is silenced, presumably by the phosphatase PP1 which releases checkpoint proteins from the
kinetochore, and Cdc20 is able to activate the APC. KNL1 is required for the kinetochore recruitment of
the SAC proteins Bub1, BubR1, Bub3, Mad1, and Mad2, and for recruitment of PP1. Figure adapted




Figure 1.7. KNL1-dependency of kinetochore protein localization. Solid arrows indicate a high
level of dependence for localization and dashed arrows indicate a partial dependence. Arrows do not







KNL1 FACILITATES PHOSPHORYLATION OF OUTER KINETOCHORE PROTEINS BY 




Congression and proper segregation of mitotic chromosomes is critically dependent on the 
interaction between spindle microtubules (MTs) and kinetochores. The strength of kinetochore– 
MT attachments must be precisely regulated to prevent the accumulation of attachment errors and 
to facilitate proper activation and silencing of the spindle assembly checkpoint (SAC). Aurora B 
kinase influences the binding affinity between kinetochores and MTs [70-72], in part through 
phosphorylation of the NDC80 complex component Hec1 [28, 36]. During early mitosis, Hec1 is 
highly phosphorylated by Aurora B, reducing its MT binding activity and preventing premature 
stabilization of kinetochore–MT attachments. Conversely, during late mitosis, Hec1 
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attachments and SAC silencing [73]. A current model to explain the marked change in Aurora B        
kinase-mediated phosphorylation posits that phosphorylation efficiency depends on the distance 
between kinetochore substrates and the permanently activated kinase that emanates as a gradient 
from the inner centromere, such that increased inter-kinetochore distance results in decreased 
levels of substrate phosphorylation [69, 74, 75]. Although protein gradients exist and can be 
sustained in the cytoplasm [76], the mechanism by how a steep, nanometer-scale gradient of active 
Aurora B arises and regulates the interaction between kinetochores and MTs is not well 
understood. Alternatively, Aurora B activity at the kinetochore may be modulated during mitotic 
progression as a result of biochemical and physical changes occurring at the kinetochore. Indeed, 
several kinetochore proteins have been demonstrated to influence Aurora B activity. However, 
little is known about the interplay between Aurora B regulators and the mechanisms by which they 
modulate Aurora B activity.  
The kinetochore-associated phosphatases PP1 and PP2A have been implicated in 
counteracting Aurora B activity to facilitate kinetochore–MT stabilization [20, 61, 62, 77]. The 
kinetochore protein KNL1 mediates recruitment of PP1 (directly) and PP2A (indirectly through 
BubR1) to kinetochores, as well as recruitment of the SAC proteins BubR1 and Bub1, which are 
known to down-regulate Aurora B kinase activity and promote Aurora B localization, respectively 
[12, 20, 62, 77, 78]. Although KNL1 is a scaffold for both positive and negative regulators of 
Aurora B activity, the consequences of KNL1 depletion in mammalian cells and its effect on 
Aurora B–mediated regulation of kinetochore–MT attachment have not been studied. Here we find 
that depletion of KNL1 or perturbation of the KNL1 N terminus abolishes Aurora B–mediated 
phosphorylation of outer kinetochore proteins, including Hec1 and Dsn1, and prevents cells from 
properly regulating kinetochore–MT attachments. This lack of phosphorylation is correlated to a 
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significant decrease in Aurora B activity at kinetochores. We show that the N terminus of KNL1 
also facilitates kinase activity of Bub1, a SAC protein known to promote Aurora B recruitment by 
phosphorylating histone H2A. However, bypassing the requirements of Bub1-mediated Aurora B 
recruitment in KNL1-depleted cells by direct targeting of Aurora B does not rescue wild-type 
levels of Aurora B activity or substrate phosphorylation, suggesting that Bub1 and KNL1 may act 
in an alternative pathway to regulate Aurora B activity. Together, our results demonstrate that 
KNL1 is essential for Aurora B kinase activity at kinetochores and for proper regulation of 
kinetochore–MT attachments.  
 
2.2 Results 
KNL1 facilitates phosphorylation of the outer kinetochore protein Hec1 
The kinetochore protein KNL1 has been described as a scaffold for both SAC proteins and 
phosphatase activities. PP1 is recruited to kinetochores by an N-terminal RVSF motif, and PP2A 
is recruited by BubR1, a well-known KNL1 interacting partner [20, 62, 77]. Both PP1 and PP2A 
are proposed to counteract Aurora B activity. In support of this, depletion of BubR1 (which recruits 
PP2A to kinetochores) or Sds22 (a PP1 regulatory subunit) results in hyperactivation of Aurora B 
[78, 79]. Based on these findings, we predicted that loss of KNL1, a hub for kinetochore Aurora 
B antagonists, would result in high levels of Hec1 phosphorylation. To test this, we depleted KNL1 
from HeLa and RPE-1 cells and quantified Hec1 phosphorylation at kinetochores (Figure 2.1A-
F). Quantification was performed in early mitotic cells, when Hec1 phosphorylation levels at 
kinetochores are highest [73]. Surprisingly, KNL1 depletion caused a significant decrease in Hec1 
phosphorylation (>80%; Figure 2.1C-F). We measured a 42% decrease in total Hec1 levels at 
kinetochores after KNL1 depletion, but measured no change in total Hec1 protein levels (Figure 
21 
 
2.1G). The reduction in Hec1 phosphorylation after KNL1 depletion was significant after 
accounting for the 42% loss of total Hec1 at kinetochores Figure 2.1H). Thus, KNL1 is required 
for Hec1 phosphorylation in early mitosis.  
 
KNL1 is required for Aurora B activation 
To determine if the observed defects in Hec1 phosphorylation upon KNL1 depletion were 
due to perturbation of Aurora B kinase activity, we evaluated levels of active Aurora B kinase in 
KNL1-depleted cells. Active Aurora B has been detected using antibodies to either auto-
phosphorylated Thr232 (pT232) [80] or phosphorylated Ser331 (pS331) [81]. Compared with 
control cells, kinetochores of KNL1-depleted cells exhibited a marked reduction of Aurora B 
pT232 and pS331 localization (Figure 2.2A-D), suggesting that KNL1 is involved in the regulation 
of Hec1 phosphorylation by facilitating recruitment and/or activation of Aurora B. Contrary to the 
bulk of centromeric Aurora B (between sister kinetochores) observed with pan-Aurora B 
antibodies, pT232 and pS331 Aurora B antibodies localize at the kinetochore region in early 
mitosis. Despite the different localization patterns, the Aurora B phosphospecific antibodies are 
not detected in cells when Aurora B is chemically inhibited [73, 81], and Western blotting with 
the pT232 antibody suggests that it primarily recognizes Aurora B (Figure 2.2C). Whether 
phosphorylated Aurora B is recruited to specific sites at the kinetochore or whether Aurora B 
localizes to multiple sites between sister kinetochores and only those molecules near the 
kinetochore are phosphorylated at T232 (and S331) is unclear. Regardless, auto-phosphorylation 
of Aurora B (a requirement for kinase activity) [80] and phosphorylation of Aurora B substrates 
significantly decrease after KNL1 depletion. Thus, we conclude that KNL1 is essential for proper 
Aurora B activity at the kinetochore.  
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Using a non-phosphospecific Aurora B antibody (AIM1), we determined if KNL1 
depletion had an effect on centromeric Aurora B localization. We found only a modest reduction 
of inner centromeric Aurora B (40%) in cells depleted of KNL1 (Figure 2.3A) compared with the 
more severe reduction of Aurora B pT232 (>80%). Strikingly, depletion of KNL1 resulted in a 
significant decrease in phosphorylation of the Aurora B substrate and chromosomal passenger 
complex (CPC) component INCENP (Figure 2.3B), indicating that activity of Aurora B at the 
inner centromere is also compromised upon KNL1 depletion. In contrast, global Aurora B activity, 
determined by phosphorylation of Ser10 histone H3 [82], did not significantly change upon 
depletion of KNL1 (Figure 2.3C). Together, our data demonstrate that KNL1 promotes activity of 
Aurora B at the centromere and kinetochore region and acts as a mediator of outer kinetochore 
protein phosphorylation.  
 
KNL1 is required for proper regulation of kinetochore–MT dynamics 
Given its role in promoting Aurora B kinase activity at kinetochores, we next probed the 
phenotypic consequences of KNL1 depletion. Lack of Aurora B kinase activity in early mitosis 
results in premature stabilization of kinetochore–MT fibers, which persist after exposing cells to 
cold-induced MT depolymerization [74, 83]. Both KNL1-depleted cells and cells treated with 
ZM447439, an Aurora B kinase inhibitor, exhibited higher spindle fluorescence intensity in early 
mitosis than control cells after cold-induced MT depolymerization (Figure 2.4A). This indicates 
that depletion of KNL1 results in premature stabilization of kinetochore–MT attachments and 
further supports the idea that KNL1 promotes Aurora B kinase activity. KNL1 depletion leads to 
a phenotype in which a population of chromosomes aligns at the spindle equator, while another 
population of chromosomes remains trapped near one or both poles (Figure 2.1A and 2.1E) [11]. 
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Interestingly, chromosomes trapped at the poles in KNL1-depleted cells generally did not exhibit 
stable, end-on kinetochore–MT attachments after cold treatment (unpublished data). Although this 
may appear inconsistent with reduced Aurora B activity at kinetochores, the result is possibly due 
to kinetochore delocalization of proteins required to mediate attachment of chromosomes stranded 
in regions of low MT density (e.g., Cenp-E) that occurs upon KNL1 depletion. Similar to previous 
observations in cells with decreased Aurora B activity or impaired Hec1 phosphorylation [36, 72, 
73], aligned chromosomes in KNL1-depleted HeLa cells exhibited abnormal chromosome 
oscillations (Figure 2.4B-D). Specifically, oscillatory movements of kinetochores in KNL1-
depleted cells were significantly dampened compared with those in control cells (Figure 2.4B–D). 
These results indicate that despite its MT-binding activity [28], KNL1 is not absolutely essential 
for the formation of end-on kinetochore–MT attachments in human cells, but is instead required 
for their proper regulation. Consistent with this idea, KNL1 MT-binding activity does not 
contribute to chromosome biorientation in Caenorhabditis elegans [29]. Together, these results 
demonstrate that KNL1 contributes to the regulation of kinetochore–MT plus-end attachment 
dynamics likely through activation of Aurora B.  
 
The N-terminal region of KNL1 is sufficient to promote Aurora B activity and 
phosphorylation of outer kinetochore proteins 
To define the domain in KNL1 required to promote Aurora B activity at kinetochores we 
generated isogenic doxycycline-inducible HeLa stable cell lines containing KNL1 fragments fused 
to GFP for use in silence and rescue experiments (Figure 2.5A). All fragments contained a small 
C-terminal region required to target KNL1 to kinetochores (aa 2056–2316, “250C”), which on its 
own was not sufficient to rescue Aurora B pT232 localization (Figure 2.5D). KNL1 fragments 
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containing portions of the N terminus (300N, 300–800N, 1500C) significantly restored Aurora B 
pT232, whereas the fragments containing only the C terminus (1200C, 800C) did not (Figure 2.5B 
and 2.5C). Similar results were obtained by transient transfection with KNL1 fragments (Figure 
2.6A-C). In all cases, GFP fluorescence intensity levels of the mutant constructs at kinetochores 
were comparable, as well as the penetrance of KNL1 depletion (Figure 2.6D-F). As expected, the 
KNL1 N terminus coordinately rescued phosphorylation of Hec1 and phosphorylation of the 
Aurora B kinetochore substrate Dsn1, whose phosphorylation was also inhibited after KNL1 
depletion (Figure 2.7A and 2.7B). KNL1 fragments lacking the N-terminal half of the protein were 
not able to significantly restore Hec1 phosphorylation, while all KNL1 fragments, including the 
short 250C fragment, facilitated wild-type levels of Hec1 recruitment to kinetochores as detected 
by a non-phosphospecific Hec1 antibody (Figure 2.7C). These results reveal a previously 
undescribed role for the KNL1 N-terminal region in promoting activity of Aurora B and 
phosphorylation of Aurora B substrates.  
We next examined the requirements of the different KNL1 regions on the localization of 
inner centromeric Aurora B. Similar to the results observed upon KNL1 depletion, cells lacking 
the N-terminal half of KNL1 (1200C, 800C) exhibited a moderate reduction in centromeric Aurora 
B accumulation (∼30–40%; Figure 2.8A). Conversely, fragments containing KNL1 N-terminal 
regions (300N, 300–800N, 1500C) almost completely reestablished centromeric Aurora B 
targeting (∼90%; Figure 2.8A), indicating that the N terminus of KNL1 is also sufficient for wild-
type levels of centromeric Aurora B enrichment. Importantly, the KNL1 300N region recovered 
high levels of centromeric Aurora B (∼90%) but only partial levels of Aurora B pT232 (∼60%). 
Thus, although the KNL1 N terminus promotes both enrichment of centromeric Aurora B and 
Aurora B auto-phosphorylation (pT232) at kinetochores, we did not observe a close quantitative 
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correlation between the levels of these two populations (Figure 2.8B). Instead, levels of 
phosphorylated INCENP (phospho-Ser893/Ser894) [75], a substrate and enhancer of Aurora B 
activity that also localizes to the inner centromere [94], correlated well with levels of Aurora B 
pT232 in all KNL1 mutant stable cell lines (Figure 2.8C). Thus, it is possible that KNL1 
differentially influences centromeric Aurora B recruitment and Aurora B activity. 
 
The N-terminal region of KNL1 rescues phenotypic defects observed upon KNL1 depletion 
In agreement with our results demonstrating different contributions of the KNL1 N 
terminus to Aurora B activity at the kinetochore, 300–800N KNL1 significantly restored 
kinetochore oscillations of aligned chromosomes, whereas cells expressing 300N only partially 
restored oscillatory movements (Figure 2.9A-C). Additionally, we measured the effect of KNL1 
depletion on the generation of tension across sister kinetochores. Contrary to a previous report 
[20], we found that inter-kinetochore distances of bi-oriented chromosomes were significantly 
increased in KNL1-depleted cells (Figure 2.9D), indicating either hyper-stabilized kinetochore–
MT connections or weakened centromere cohesion [36, 84]. Consistently, 300N and 300–800N 
KNL1 significantly restored inter-kinetochore distances of aligned chromosomes to control values 
(Figure 2.9D). Thus, the KNL1 N terminus is critical for Aurora B activity at the kinetochore and 
for normal kinetochore–MT dynamics in cells. 
 
KNL1 N terminus facilitates Bub1 kinase activity at kinetochores 
The N terminus of KNL1 serves to recruit multiple outer kinetochore proteins implicated 
in the modulation of Aurora B activity [12, 20, 62]. We therefore examined if KNL1 promotes 
Aurora B activity by mediating the recruitment of these regulatory factors. Silence and rescue with 
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a KNL1 construct in which the PP1-binding motif (RVSF) was disrupted [20] did not affect 
kinetochore levels of Aurora B pT232, nor did depletion of BubR1 (Figure 2.10A-B). Bub1 
depletion, in contrast, led to reduced Aurora B pT232 levels, and this resulted in decreased Hec1 
phosphorylation (Figure 2.11A). These data are in agreement with recent findings suggesting that 
Bub1 kinase promotes Aurora B activation [85, 86]. Thus, the ability of KNL1 to promote Aurora 
B recruitment and activation could depend on its function as a kinetochore scaffold for Bub1. The 
KNL1 N terminus, which we find indispensable for Aurora B activity at the kinetochore, contains 
multiple MELT motifs that upon Mps1-mediated phosphorylation allow for direct recruitment of 
Bub1 [23, 25, 26]. Interestingly, although all KNL1 constructs capable of recovering significant 
levels of Aurora B pT232 localization contain at least 1 MELT repeat (Figure 2.6A), not all are 
able to mediate Bub1 kinetochore accumulation (Figure 2.11B and 2.11C). Fragments 300–800N 
(4 MELT repeats) and 1500C (5 MELT repeats) highly restored Bub1 localization to kinetochores 
(Figure 2.11B; unpublished data). In contrast, 300N (1 MELT repeat) was unable to mediate Bub1 
kinetochore localization, even upon nocodazole treatment (Figure 2.11B-D). Thus, our data 
suggest that Bub1 accumulation at kinetochores enhances Aurora B activation and inner 
centromere Aurora B targeting, but it is not a requisite for these processes to occur.  
Because the 300 N-terminal amino acids of KNL1 are not necessary or sufficient for 
accumulation of Bub1 at kinetochores, but mediate centromeric Aurora B accumulation and partial 
Aurora B activity, we asked if this region on KNL1 could facilitate Bub1 kinase activity. By 
analyzing the levels of histone H2A phosphorylation (T120), a well-described Bub1 kinetochore 
substrate [87], we found evidence of significant Bub1 kinase activity at kinetochores in cells 
expressing 300N KNL1 or 300–800N KNL1 but negligible activity when KNL1 was depleted or 
replaced with C-terminal fragments. Specifically, cells expressing the 300–800N fragment rescued 
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pH2A-T120 to 70%, and those expressing the 300N fragment to 55% (Figure 2.12A). Thus, the 
N-terminal region of KNL1 facilitates both Aurora B and Bub1 kinase activities at the kinetochore. 
Importantly, the 300–800N fragment recruits significantly higher levels of Bub1 to kinetochores 
than the 300N fragment, and this corresponds to a high level of both Aurora B and Bub1 kinase 
activities. These results suggest that Bub1 accumulation at kinetochores is required for wild-type 
levels of Aurora B–mediated phospho-regulation of kinetochore–MTs in cells.  
Previous studies mapped the binding of the Bub1 tetratricopeptide repeats (TPRs) domain 
to aa 200–250 in the N-terminal region of KNL1 (referred to as the KI motif) [13]. Recently, 
however, and in agreement with our results, it was demonstrated that the Bub1 TPR domain is not 
sufficient for Bub1 localization to kinetochores [22, 26]. Furthermore, the catalytic activity of 
Bub1 measured in vitro was not affected by expression of a Bub1 mutant unable to interact with 
the KI motif of KNL1 [22]. Similarly, silence and rescue experiments in mammalian cells using a 
mutant of KNL1 lacking the KI motif confirmed that the TPR–KI interaction is dispensable for 
Bub1 localization to kinetochores [26]. Therefore, we hypothesized that a 300N KNL1 fragment 
containing mutations in the KI motif predicted to disrupt the KNL1–TPR interaction [22], would 
not impair Bub1 kinase activity in cells. Indeed, silence and rescue experiments using a GFP-
tagged 300N KNL1-KI mutant (Figure 2.12B) confirmed that the ability of the KNL1 300N 
fragment to mediate Bub1 kinase activity does not rely on its KI motif (Figure 2.12C). We next 
examined if disruption of the MELT motif contained in the 300N KNL1 region disrupted Bub1-
mediated histone H2A phosphorylation. Surprisingly, a 300N KNL1 mutant containing an alanine 
substitution in the single MELT motif (MELA) was able to mediate histone H2A phosphorylation 
in cells (Figure 2.12C). Therefore, neither the KI nor the MELT motif in the 300N region of KNL1 
are essential for Bub1 kinase activity at kinetochores. How the 300N-terminal region of KNL1 is 
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able to mediate Bub1 and Aurora B kinase activities remains to be addressed. One possibility, 
however, is that Bub1 interaction with 300N KNL1, even transiently, results in close positioning 
of the kinase to its substrate (H2A). Alternatively, a transient interaction with KNL1 could promote 
allosteric changes in Bub1 that enhance its activation.  
 
KNL1 is required for full Aurora B activity independent of Aurora B accumulation 
Bub1 promotes Aurora B recruitment to the inner centromere through phosphorylation of 
histone H2A, which results in targeting of Borealin, a CPC component [88]. It is proposed that 
accumulation at this inner centromeric site results in Aurora B activation and a gradient of active 
kinase emanating toward the kinetochore to regulate kinetochore–MT interactions [75]. Therefore, 
it is possible that KNL1 contributes to Aurora B activity entirely by facilitating Bub1-mediated 
Aurora B recruitment. Our data, however, suggest distinct contributions of KNL1 to Aurora B 
localization and Aurora B activity (Figures 2.2, 2.3, 2.5, 2.8). We therefore hypothesized that 
KNL1 not only contributes to Aurora B activity by promoting its recruitment but also through an 
alternative pathway. To directly test this, we targeted Aurora B to the kinetochore through a Cenp-
B (CB)–INCENP chimera [74] and to the inner centromere through an HP1-Survivin chimera 
(Figure 2.13A). Endogenous Aurora B, detected using pan-antibodies and antibodies to its 
phosphorylated form (pT232), was redistributed to kinetochores or to the inner centromere in cells 
expressing CB-INCENP or HP1-Survivin, respectively (Figure 2.13B). We quantified the levels 
of both Aurora B and Aurora B pT232 colocalizing with these fusion proteins in control and 
KNL1-depleted cells (Figure 2.13C-E and 2.14A-D). Although control and KNL1-depleted cells 
were able to recruit similar levels of Aurora B in the presence of the targeting chimeras (Figure 
2.13E), Aurora B pT232 and substrate phosphorylation were not fully restored in KNL1-depleted 
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cells (Figure 2.13C, 2.13D, 2.13F). Although ectopic targeting of Aurora B to these regions may 
not reflect endogenous kinase activity, these results argue that kinase accumulation is not sufficient 
to achieve control levels of kinase activity in the absence of KNL1. Therefore, it is likely that the 
influence of KNL1 on Aurora B activity at kinetochores is not exclusively dependent on Bub1-
mediated recruitment of the kinase.  
 
2.3 Discussion 
KNL1 is widely recognized as a kinetochore scaffolding protein that contributes to the 
formation of kinetochore–MT attachments and is required for accurate chromosome segregation 
during mitosis [40]. Studies in C. elegans and mammalian cells have demonstrated its involvement 
in the recruitment of SAC proteins (Bub1, BubR1) [12] and phosphatases (PP1 and PP2A via 
BubR1) to kinetochores [20, 62,77] as well as its ability to bind MTs [29, 69]. KNL1 is proposed 
to be required for initial activation of the SAC [12], and for checkpoint silencing [29, 63, 65], yet 
how this large kinetochore protein of unknown structure contributes to different signaling 
pathways temporally throughout mitosis is not well understood. Adding more complexity, Bub1, 
BubR1, and the phosphatases PP1 and PP2A are regulators of Aurora B [12, 20, 62, 77, 78], the 
kinase considered the “master regulator” of kinetochore–MT attachments during mitosis. Based 
on its role in recruiting proteins that impact Aurora B function, we reasoned that KNL1 might be 
critical for the proper regulation of Aurora B activity. We found that KNL1 is required for Aurora 
B activity and for Aurora B–mediated phosphorylation of outer kinetochore proteins including 
Hec1, the primary kinetochore–MT attachment protein, and Dsn1, a member of the kinetochore-
associated Mis12 complex, which also contributes to the formation of stable kinetochore–MT 
attachments [38]. We identified the N-terminal half of KNL1 (aa 1–1200N) as sufficient to mediate 
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such activities. In addition, the N-terminal region of KNL1 sufficient to promote Aurora B activity 
and substrate phosphorylation is also required for Bub1-mediated histone H2A phosphorylation, a 
known contributor to Aurora B centromeric localization [89]. Previously, it was unclear if Bub1 
accumulation to kinetochores was required for Bub1 to perform its functions. Here we found that 
KNL1-mediated Bub1 accumulation to kinetochores is not a requirement for its activity at 
kinetochores. However, the N-terminal region of KNL1 is necessary and sufficient to facilitate 
Bub1 kinase activity. The levels of Bub1 kinase activity, measured by the levels of 
phosphorylation of its substrate, histone H2A, correlate with the levels of Aurora B activity. Thus, 
we propose that KNL1 promotes Aurora B activation and Aurora B–mediated phosphorylation by 
facilitating Bub1 kinase activity during early mitosis (Figure 2.15). Importantly, although Bub1 
functions upstream of Aurora B targeting, localization of Aurora B by ectopic targeting in the 
absence of KNL1 did not result in full Aurora B activity. Therefore, KNL1 and Bub1 may 
influence Aurora B activity in a manner that is distinct from their roles in targeting the kinase to 
centromeres. The interplay between Bub1 and Aurora B kinase activities at kinetochores and how 
Bub1 interaction with KNL1 could modulate Bub1 function during mitotic progression are issues 
that remain to be addressed. 
The current model describing the regulation of kinetochore–MT attachment strength during 
mitosis proposes that Aurora B, emanating as a gradient from the inner centromere, selectively 
reaches kinetochore proteins by diffusion, depending on their distance from the origin of the 
gradient [74, 75]. However, it has been demonstrated both in chicken cells and in budding yeast 
that mitotic chromosomes are able to accurately bi-orient and segregate in absence of centromeric 
Aurora B [90, 91]. In agreement with these studies, we find that in the absence of KNL1, 
significant levels of centromeric Aurora B or ectopic targeting of Aurora B do not result in control 
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levels of Aurora B activity as the previously described model proposes. We find that maintenance 
of Aurora B activity, promoted by the N terminus of KNL1, correlates with Bub1 activity at 
kinetochores (which is low during late mitosis, when checkpoint proteins no longer accumulate at 
kinetochores). Thus, an alternative model for the regulation of kinetochore–MT attachment 
suggests that levels of active Aurora B at kinetochores are modulated during mitotic progression 
as a result of changes in Bub1 kinase activity (Figure 2.15). Specifically, it is possible that changes 
at the kinetochore during late mitosis result in decreased KNL1-mediated Bub1 kinase activity and 
Aurora B–mediated phosphorylation of kinetochore substrates. Our results demonstrating Bub1’s 
contribution to Aurora B activity at the kinetochore support the notion that a single sensory 
mechanism may be used for both MT turnover/error correction and checkpoint signaling (Figure 
2.15) [9]. A previously demonstrated role for Bub1 in chromosome congression [49] is likely to 
be linked to the maintenance of Aurora B activity at the kinetochore. Conversely, a role for Aurora 
B in checkpoint signaling may be to not only prevent premature checkpoint silencing (by stalling 




Cell culture and transfection 
HeLa (ATCC) and RPE1 cells (hTERT-RPE1; ATCC) were cultured in DMEM and 
DMEM/F12 (Invitrogen), respectively, supplemented with 10% FBS and 1% 
penicillin/streptomycin at 37°C in 5% CO2. For immunostaining experiments after KNL1 
depletion, cells were synchronized in early mitosis using a double thymidine block and release. 
Cells were treated with 2.5 mM thymidine for 16 h, washed with PBS, replaced with fresh medium, 
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transfected with siRNA, and incubated for 8 h. For the second block, cells were transfected with 
siRNA and treated with 2.5 mM thymidine for 16 h. Cells were then washed with PBS, replaced 
with fresh medium, and fixed after 10 h for immunostaining. For all experiments, cells were plated 
at 50% confluency 24 h before transfection or thymidine treatment on acid-washed glass coverslips 
for immunofluorescence or on glass-bottomed dishes for live-cell imaging (MatTek Corporation). 
For experiments with ZM447439, cells were treated with 2 µM ZM447439 for 2 h before fixing 
or harvesting. For cold-induced depolymerization assays, cells were incubated in ice-cold DMEM 
for 10 min, fixed with paraformaldehyde, and prepared for immunofluorescence as described 
below. siRNA transfections were performed using Oligofectamine (Invitrogen), according to the 
manufacturer’s instructions, and cells were analyzed 48 h after transfection. For KNL1 silence and 
rescue experiments, cells were transfected with siRNA, 8 h later with plasmid DNA using 
Effectene (QIAGEN), and analyzed 48 h after DNA transfection. siRNAs targeting KNL1 were 
purchased from Invitrogen. The sequences for “stealth” siRNAs were 5′-
GAACACAUUGCUUUCUGCUCCCAUU-3′, 5′-GGGCAGGAUGACAUGGAGAUCACUA-
3′, and 5′-AAGAUCUGAUUAAGGAUCCACGAAA-3′. The siRNA used for KNL1 silence and 
rescue experiments for wild-type and RVSF/AAAA plasmids [20] was synthesized by QIAGEN 
(5′-AAGGAAUCCAAUGCUUUGAGA-3′). Bub1 siRNA was 5′-
CAGCUUGUGAUAAAGAGUCAA-3′ and BubR1 siRNA was 5′-
ACGAGAAUACCUAAUAUGUGA-3′, both purchased from QIAGEN. Luciferase siRNA 
(QIAGEN) was used as control in all experiments displayed in Figures 2.1 and 2.2. 
The FlpIn T-REx HeLa host cell line was a gift from S. Taylor (University of Manchester, 
Manchester, England, UK). To generate FlpIn T-REx HeLa cells containing KNL1 fragments 
fused to GFP at the N terminus, Flp-In T-REx HeLa host cells were cotransfected with a ratio of 
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9:1 (wt/wt) pOG44:pcDNA5/FRT/TO expression plasmid using Fugene HD (Promega). 48 h after 
transfection, cell lines were placed under selection with 100 µg/ml hygromycin (EMD Millipore) 
for 2 wk. Hygromycin-resistant foci were chosen, expanded, and tested for GFP expression. Gene 
expression was induced with 1 µg/ml doxycycline (Sigma-Aldrich) for 24 h. For silence and rescue 
experiments, stable cell lines were doubly blocked with thymidine and depleted of endogenous 
KNL1 using the corresponding siRNAs described above.  
 
Plasmids 
The siRNA-resistant KNL1 wild-type and RVSFAAAA mutant plasmids were a gift from 
M. Lampson (University of Pennsylvania, Philadelphia, PA). The GFP-tagged KNL1 fragments 
were as follows: amino acids 1–300 (300N), 300–818 (300–800N), 819–1518 (800–1500N), 
1174–2316 (1200C), 1519–2316 (800C), 819–2316 (1500C), 2056–2316 (250C), and 1834–2316 
(400C), and were generated by PCR using KNL1 wild-type as the template [74] and cloned into 
the pEGF-C2 vector and pcDNA5/FRT/TO vector using In-Fusion cloning (Takara Bio Inc.). The 
KNL1 fragments KNL1 300N, 300–800N, and 800–1500N were cloned into pEGFP-C2 and/or 
pcDNA5/FRT/TO containing the KNL1 kinetochore-binding region (aa 2056–2316). Constructs 
800–1500N and 1500C differ from the sequence published in Bolanos-Garcia et al. (2011) [21], 
in that aa 910–1120 are not contained. The GFP-tagged CB-INCENP plasmid containing hCenp-
B aa 1–158 and hINCENP aa 47–920 was a gift from S. Lens (University Medical Center, Utrecht, 
Netherlands). The GFP-HP1-Survivin construct was generated as follows: full-length Survivin and 
HP1 were obtained by RT-PCR from HeLa cells. Survivin was cloned into pEGFP-C2 to generate 
GFP-Survivin, and HP1 was cloned into GFP-Survivin to generate GFP-HP1-Survivin. All 




Fixation and immunostaining of HeLa and RPE-1 cells were performed as described 
previously [73]. In brief, cells were rinsed in 37°C PHEM buffer (60 mM Pipes, 25 mM Hepes, 
10 mM EGTA, and 4 mM MgSO4, pH 6.9), fixed in in 4% paraformaldehyde for 20 min, and 
extracted in PHEM buffer + 0.5% Triton X-100 for 5 min. Staining of phospho-Ser331 Aurora B 
was performed as described in Petsalaki et al. (2011) [81]. In brief, cells were rinsed in PHEM 
buffer, extracted in PHEM buffer + 0.5% CHAPS for 5 min, and fixed with cold methanol for 5 
min at 20°C. Immunostaining was performed using the following antibodies: rabbit polyclonal 
anti-phosphorylated Ser44-Hec1 (pSer44 against antigen PTFGKL(pS)INKPTSE) and anti-
phosphorylated Ser55-Hec1 (pSer55 against antigen KPTSERKV(pS)LFGKR) were used at 
1:2,000; mouse anti-Hec1 9G3 at 1:2,000 (GeneTex); rabbit anti-Dsn1 at 1:500 (GeneTex); human 
anti-centromere antibody at 1:500 (ACA; Antibodies, Inc.); mouse anti-tubulin at 1:200 (Sigma-
Aldrich); sheep anti-tubulin at 1:300 (Cytoskeleton, Inc.); rabbit anti-phosphorylated Aurora B 
(pThr232) at 1:2,000 (Rockland); rabbit anti-phosphorylated Aurora-B (pSer331, against peptide 
CPWVRAN(pS)RRVLPPS); a gift from G. Zachos [University of Crete, Heraklion, Greece]) at 
1:100; mouse anti-BubR1 at 1:500 (EMD Millipore); rabbit anti-phosphorylated INCENP 
(Ser893/Ser894, against peptide RYHKRT(pS)(pS)AVWNSPC); a gift from M. Lampson) at 
1:1,000; rabbit anti-phosphorylated Dsn1 (Ser109 against peptide TNRRK(pS)LHPIH); a gift 
from I. Cheeseman [Whitehead Institute, Cambridge, MA]) at 1:1,000; rabbit anti-phosphorylated 
histone H2A (Thr120) at 1:1,000 (Active Motif); mouse anti-Bub1 at 1:200 (Abcam); mouse anti–
Aurora B monoclonal (AIM1) at 1:300 (BD); and mouse anti-phosphorylated histone H3 (Ser10; 
Cell Signaling Technology) at 1:1,000. Affinity-purified antibodies against KNL1 were generated 
at 21st Century Biochemicals; rabbits were immunized with the following KNL1 peptide: 
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MDGVSSEANEENDNIERPVRRR, and serum was double affinity purified. Secondary 
antibodies conjugated to either Alexa 647, Alexa 488, or Rhodamine Red-X (Jackson 
ImmunoResearch Laboratories, Inc.) were used at 1:300.  
 
Image acquisition and analysis 
Image acquisition was performed on an imaging system (DeltaVision Personal DV; 
Applied Precision) equipped with a camera (CoolSNAP HQ2; Photometrics/Roper Scientific), a 
60×/1.42 NA PlanApochromat objective (Olympus), and SoftWoRx acquisition software (Applied 
Precision). For fixed cell experiments, images were acquired at room temperature as Z-stacks at 
0.2-µm intervals and kinetochore fluorescence intensity measurements were performed using 
MetaMorph software (Molecular Devices). The integrated fluorescence intensity minus the 
calculated background was determined for each kinetochore in control and treated samples and 
normalized to the average value obtained from control cells [92]. Inter-kinetochore distances were 
determined using SoftWorx software. For live-cell imaging of kinetochore oscillations, HeLa cells 
in 35-mm glass-bottomed dishes (MatTek Corporation) were transfected with KNL1 siRNA and 
24 h later with 0.2 µg of GFP-CENP-B (a gift from K. Sullivan, NUI Galway, Galway, Ireland) 
and GFP-centrin (a gift from M. Bornens, Institut Curie, Paris, France) as described above. Cells 
were imaged 24 h after DNA transfection in Leibovitz’s L-15 media (Invitrogen) supplemented 
with 10% FBS, 7 mM Hepes, pH 7.0, and 4.5 g/L glucose. Stage temperature was maintained at 
37°C with an environmental chamber (Precision Control). Fluorescence images of GFP-CENP-
B/GFP-centrin–expressing cells were acquired every 3 s for 10 min. At each time point, 5 images 
were collected in a Z-series, using a 0.5-µm step size. Cells chosen for analysis expressed both 
GFP-CENP-B and centrin-GFP proteins and were in late prometaphase or metaphase with 
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primarily bi-oriented chromosomes. Sister kinetochore pairs chosen for analysis were located 
within the middle of the spindle. Kinetochore and spindle pole movements were tracked using 
CENP-B-GFP fluorescence and centrin-GFP fluorescence, respectively, on maximum projection 
time-lapse sequences using MetaMorph software. The spindle pole marker centrin was used to 
correct for cell movement during the time-lapse imaging sequence. Kinetochore movements were 
tracked on maximum projection time-lapse sequences using the “track points” function in 
MetaMorph software. Tracking data were analyzed in Microsoft Excel. A “pause” event was 
recorded when a kinetochore did not move for two sequential time frames. Velocity was calculated 
by linear regression analysis of kinetochore distance versus time plots, and deviation from average 
position (DAP) was determined by subtracting the position of the kinetochore in the regression 
line from the original kinetochore position [73, 93]. Kinetochore oscillation analysis in HeLa TRex 
FlpIn stable cell lines was performed as described above, with the exception that cells were 
expressing mCherry tagged CenpB. For live-cell imaging with mCherry-Bub1, 300N KNL1 HeLa 
stable cells were transfected with 0.3 µg mCherry-Bub1 and imaged 48 h after DNA transfection 
in filming medium containing 330 nM nocodazole. All presented data were analyzed in SigmaPlot 
software v.11.0 (Systat Software) and the statistical tests performed are specified in figure legends.  
 
Immunoprecipitation and immunoblotting 
Cells were lysed in lysis buffer (75 mM Hepes, pH 7.5, 150 mM KCl, 1.5 mM EGTA, 1.5 
mM MgCl2, 0.1% NP-40, Complete protease inhibitor cocktail [Roche], and PhosSTOP 
phosphatase inhibitors [Roche]. Western blotting was performed using the following antibodies: 
anti-Hec1 9G3 at 1:1,000 (GeneTex); rabbit anti-phosphorylated Aurora B (pThr232) at 1:100 
(Rockland); rabbit anti–Aurora B at 1:1,000 (Abcam); rabbit anti-KNL1 at 1:500; mouse anti–β-
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actin at 1:500 (Abcam); and mouse anti-tubulin at 1:2,000 (Sigma-Aldrich). For 
immunoprecipitation assays, lysates were incubated with mouse anti–Aurora B (mouse AIM1; 
BD) for 2 h at 4°C, and with a mix of Sepharose protein A/G (Bio-Rad Laboratories) for an 
additional 2 h at 4°C. The unbound fraction was recovered and beads were washed with lysis buffer 




Figure 2.1. KNL1 is required for Aurora B kinase-mediated Hec1 phosphorylation at the
kinetochore. (A) Control and KNL1-depleted HeLa cells immunostained with KNL1 and tubulin
antibodies. Kinetochore fluorescence intensities were measured after KNL1 depletion using a KNL1
antibody. Error bars represent s.d. from independent experiments (n=3). For each experiment n≥100
kinetochores were measured from at least 10 cells. (B) Western blot of HeLa cell extracts from control
and KNL1 siRNA-treated cells immunostained with KNL1 and β-actin antibodies. Percentage lysate
loaded in the gel is indicated. Quantification of band intensities indicates that KNL1 levels were
decreased by 96%. (C-D) Control and KNL1-depleted HeLa cells were immunostained with Hec1
phospho-specific antibodies and kinetochore fluorescence intensities were quantified. Error bars in graphs
represent s.d. from independent experiments (n=3 for Hec1 pSer44; n=2 for Hec1 pSer55). For each
experiment n≥100 kinetochores were measured from at least 10 cells. ***p<0.001 (Mann-Whitney rank







Figure 2.1. KNL1 is required for Aurora B kinase-mediated Hec1 phosphorylation at the
kinetochore. (E) RPE-1 cells demonstrating the characteristic phenotype of KNL1 depletion. (F) Control
and KNL1-depleted RPE-1 cells were immunostained with a Hec1 phospho-specific antibody, pSer44.
(G) Control and KNL1-depleted HeLa cells were immunostained with a non-phospho-specific Hec1
antibody (9G3) and kinetochore fluorescence intensities were quantified. Fluorescence intensities are
indicated as percentages in (G, left). (G) (right) Western blot of control and KNL1-depleted HeLa
extracts. Blots were probed with antibodies to Hec1 and tubulin as a loading control. (H) Levels of
phospho-Hec1 remaining at kinetochores calculated as a ratio of phospho-Hec1 fluorescence intensities
from (C) and (D) to total Hec1 remaining at kinetochores after KNL1 depletion (58%) in (G). See (C)




Figure 2.2. KNL1 is required for Aurora B activity at the kinetochore. (A) Control and KNL1-
depleted HeLa cells were immunostained with a phospho-specific Aurora B antibody (pT232) and
kinetochore fluorescence intensities were quantified. Error bars in graphs represent s.d. from independent
experiments (n=3 for Aurora B pT232). For each experiment n≥100 kinetochores were measured from at
least 10 cells. ***p<0.001 (Mann-Whitney rank sum test). (B) Control and KNL1-depleted RPE-1 cells
were immunostained with an Aurora B phospho-specific antibody, pT232. As shown in HeLa cells,
localization of pT232 is also reduced in RPE-1 cells upon KNL1 depletion. (C) Western blot of HeLa cell
lysates probed with the Aurora B pT232 antibody. Input represents 5% of total protein used for
immunoprecipitation assay. Input lane shows that the pT232 antibody primarily recognizes a band at 40
kDa (right), the same size at which Aurora B is recognized by a pan-Aurora B antibody (left). The
unbound lane represents cell lysate after Aurora B immunodepletion using a pan-Aurora B antibody
(same amount of total protein as input lane, left). The intensity of the pT232 band is significantly
decreased when lysates were immunodepleted of Aurora B (right). (D) Control and KNL1-depleted HeLa
cells were fixed and immunostained with a phospho-specific antibody to Aurora B kinase, p-Ser331 [81].
This antibody recognizes phosphorylated Aurora B kinase at the kinetochore in control cells (top panel),
however this localization is reduced in cells depleted of KNL1 (lower panel). Quantification is shown to









Figure 2.3. KNL1 is required for full Aurora B activity at the inner centromere. (A-C) Control and
KNL1-depleted HeLa cells were immunostained with a pan antibody to Aurora B kinase (AIM1) (A), a
phospho-specific antibody to INCENP (pSer893/pSer894) [75] (B), or a phospho-specific antibody to
histone H3 (pSer10) (C). Kinetochore fluorescence intensities are shown in (A). Error bars represent s.d.
from independent experiments (n=3). For each experiment n≥100 kinetochores were measured from at




Figure 2.4. KNL1 is required for wild-type kinetochore-MT dynamics. (A) Representative images of
control, ZM-treated and KNL1-depleted early mitotic HeLa cells subjected to a cold-induced MT
depolymerization assay and immunostained for tubulin and a kinetochore marker (ACA). Total spindle
fluorescence intensities are shown for each condition. Error bars in graph represent s.d. from
independent experiments (n=2). For each experiment n≥8 cells per condition. ***p<0.001 (Mann-
Whitney rank sum test), NS= not statistically significantly different. (B) Kymographs of sister
kinetochore pairs from live-cell time-lapse imaging sequences in control and KNL1-depleted HeLa cells.
Kymographs were generated from the kinetochore pairs indicated in the panels below (arrows). (C) Plots
of kinetochore tracks over time in control and KNL1-depleted HeLa cells. For each condition, two
representative sister kinetochore pairs are shown. (D) Quantification of kinetochore oscillations in
control and KNL1-depleted cells. DAP indicates deviation from average position, a measure of
oscillation amplitude [93]. Error bars represent s.d. from independent experiments (n=3). For each






Figure 2.5. The N-terminus of KNL1 promotes Aurora B activity. (A) Schematic of GFP-KNL1
constructs stably incorporated into Flp-In T-REx HeLa cell lines; the exact amino acids of all KNL1
constructs shown are as follows: amino acids 1-300 (300N), 300-818 (300-800N), 1174-2316 (1200C)
1519-2316 (800C), 819-2316 (1500C), 2056-2316 (C). (B-C) Flp-In T-REx HeLa cells were depleted
of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon doxycycline addition and
immunostained with a phospho-specific Aurora B antibody (pT232). Kinetochore fluorescence
intensities were quantified as indicated in (C). Error bars represent s.d. from independent experiments
(n=3). For each experiment n≥100 kinetochores were measured from at least 8 cells. ***p<0.001,
**p<0.05, NS= not statistically significantly different (Mann-Whitney rank sum test). Scale bars, 5 µm.
(D) KNL1-depleted HeLa cells were depleted of endogenous KNL1, rescued with the indicated GFP-
KNL1 fragment by overexpression, and immunostained with a phospho-specific Aurora B antibody





Figure 2.6. The N-terminus of KNL1 is sufficient to facilitate Aurora B activity. (A) Schematic of
constructs used in silence/rescue transient expression experiments. “N” refers to amino acids from the N-
terminus of the protein. “C” refers to amino acids from the C-terminus of the protein. Asterisks mark the
MELT repeats present in the KNL1 constructs used in the study [23, 26]. The full-length KNL1
sequence is similar to the KNL1 sequence published in Liu et al 2010 [12]. The exact amino acids
included in each construct are listed in Experimental Procedures. (B) Full-length KNL1 (KNL-WT)
rescues the KNL1 depletion phenotype in HeLa cells. (C-D) HeLa cells were depleted of endogenous
KNL1, rescued with the indicated GFP-KNL1 construct and immunostained with antibodies to Aurora B
pT232 (pABK). Kinetochore fluorescence intensities of pABK (C) and KNL1-GFP fusion proteins (D)
in silence/rescue experiments were quantified. Error bars represent s.d. from independent experiments
(n=2). For each experiment n≥60 kinetochores were measured from at least 5 cells. ***p<0.001 (Mann-
Whitney rank sum test). (E) Quantification of KNL1-GFP fusion protein levels at kinetochores in
doxycycline-induced stable cell lines. Data represent at least 12 kinetochores from at least 3 cells, n=3
independent experiments. (F) Quantification of endogenous KNL1 fluorescence intensity in the
indicated HeLa inducible cell lines. Levels of endogenous KNL1 in cells rescued with the 300N
fragment were examined with a KNL1 antibody targeted to amino acids 1413-1624 [11]. Levels of
endogenous KNL1 in cells rescued with the 300-800N or the 1200C fragment were examined with a
KNL1 antibody targeted to amino acids 1-22 (Experimental Procedures). For each experiment n≥60
kinetochores were measured from at least 5 cells. ***p<0.001 (Mann-Whitney rank sum test). Error bars
represent s.d. from 2 independent experiments. For each experiment at least 12 kinetochores were






Figure 2.7. The N-terminus of KNL1 promotes Aurora B-mediated phosphoryaltion. (A-C) Flp-In
T-REx HeLa cells were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1
fragment upon doxycycline addition and immunostained with the indicated antibodies. Kinetochore
fluorescence intensities were quantified as indicated in the graphs. (A-B) Error bars represent s.d. from
independent experiments, (A) Hec1 pSer44 (n=2), (B) pDsn1 (n=3). For each experiment n≥100
kinetochores were measured from at least 5 cells. ***p<0.001, **p<0.05, NS= not statistically
significantly different (Mann-Whitney rank sum test). (B) The 300N cell line is shown in the panel for
control and KNL1 siRNA. (C) Quantification of kinetochore fluorescence intensities measured using
the Hec1 9G3 antibody in stable HeLa FlpIn T-Rex cell lines expressing KNL1 fragments. Error bars
represent s.d. between cells; n≥100 kinetochores and n≥5 cells. No statistical differences were found





Figure 2.8. The N-terminus of KNL1 promotes centromeric Aurora B activity. (A,C) Flp-In T-REx
HeLa cells were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon
doxycycline addition and immunostained with the indicated antibodies. Kinetochore fluorescence
intensities were quantified as indicated in the graphs. (A) Error bars represent s.d. from independent
experiments (n=3). For each experiment n≥100 kinetochores were measured from at least 8 cells. (C)
The data shown are from a single representative experiment out of two repeats. For the experiment
shown, n≥100 kinetochores and n≥5 cells. The 300N cell line is shown in the panel for control and
KNL1 siRNA. Error bars represent s.d. between cells (Mann-Whitney rank sum test). (A,C)
***p<0.001, **p<0.05, NS= not statistically significantly different (Mann-Whitney rank sum test). (D)
Ratios between the average Aurora B pT232 and pINCENP fluorescence intensities and between
Aurora B pT232 and AIM1 fluorescence intensities for each KNL1-mutant cell line are shown as bar
graphs. The pT232/pINCENP ratio suggests that pT232 and pINCENP levels are highly correlated
between cell lines. The pT232/cenABK(AIM1) ratio suggests that pT232 and cenABK are not highly




Figure 2.9. The KNL1 N-terminus partially rescues wild-type MT dynamics and kinetochore-MT
attachment regulation. (A-D) Flp-In T-REx HeLa cells were depleted of endogenous KNL1, rescued
with the indicated GFP-KNL1 fragment upon doxycycline addition and analyzed for oscillatory
kinetochore movements and inter-kinetochore distances in metaphase. (A) Kymographs of sister
kinetochore pairs from live-cell time-lapse imaging sequences. Scale bar, 1 µm. (B) Plots of kinetochore
tracks over time in cells expressing the indicated fragments. (C) Quantification of kinetochore
oscillations. DAP indicates deviation from average position; n≥12 kinetochores per cell line. Error bars
represent s.d. between cells. ***p<0.001 (t- test). (D) Inter-kinetochore distances were measured on bi-
oriented sister kinetochore pairs using ACA as a kinetochore marker. Error bars represent s.d. from
independent experiments (n=3). For each experiment n≥100 kinetochores were measured from at least 5






Figure 2.10. KNL1 mediates Aurora B activity in a BubR1 and PP1 recruitment independent
manner. (A) Control and BubR1-depleted HeLa cells were fixed and stained with pT232 phospho-
specific Aurora B kinase and BubR1 antibodies. (B) HeLa cells were depleted of KNL1, rescued with
the indicated GFP-KNL1 mutant (RVSF/AAAA), and stained with the pT232 antibody. Scale bars, 5




Figure 2.11. KNL1 mediates Aurora B activity in a Bub1-accumulation independent manner.
(A) Control and Bub1-depleted HeLa cells were immunostained with antibodies to Aurora B pT232 (left
panels) or Hec1 pSer44 (right panels). Kinetochore fluorescence intensities are shown. Error bars
represent s.d. from independent experiments (n=2). For each experiment n≥50 kinetochores were
measured from at least 6 cells. (B-C) Flp-In T-REx HeLa cells were depleted of endogenous KNL1,
rescued with the indicated GFP-KNL1 fragment upon doxycycline addition, and immunostained with
Bub1 (B), or hBub1-mCherry was overexpressed (C). (B) Kinetochore fluorescence intensities were
quantified. Error bars represent s.d. from independent experiments (n=3). For each experiment n≥100
kinetochores, n≥10 cells. ***p<0.001, NS= not statistically significantly different (Student’s t-test). (C)
Live-cell imaging in control and 300N KNL1 cells expressing Bub1-mCherry and treated with
nocodazole. Time is indicated in minutes. Upon KNL1 depletion 90% of cells had no detectable Bub1,






Figure 2.11. KNL1 mediates Aurora B activity in a Bub1-accumulation independent manner. (D)
HeLa FlpIn KNL1 300N and 300-800N stable cell lines were depleted of KNL1 and rescued upon
doxycycline addition. Cells were synchronized via a double-thymidine block and treated with 30 μM
nocodazole for 3 hours. Cells were subsequently fixed and immunostained with KNL1 and Bub1
antibodies. Scale bars, 5 µm.
D
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Figure 2.12. KNL1 N-terminus is required for Bub1 kinase activity at the kinetochore. (A) Flp-In T-
REx HeLa cells were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment
upon doxycycline addition, and immunostained with histone H2A pT120. Kinetochore fluorescence
intensities were quantified. Error bars represent s.d. from independent experiments (n=2). For each
experiment n≥50 kinetochores, n≥5 cells in. ***p<0.001, NS= not statistically significantly different
(Student’s t-test). (B) Schematic of GFP-KNL1 300N fragments containing mutations in the MELT or KI
motifs. The wild-type (top) and mutated (bottom) sequences are shown. (C) HeLa cells depleted of
endogenous KNL1 were rescued with N-terminal GFP-tagged 300N, 300N-KI (300N-KI/A) or 300N-
MELT (300N-MELT/A) mutants and immunostained for histone H2A pT120. Scale bars, 5 µm (cell




Figure 2.13. Aurora B accumulation is not sufficient for wild-type levels of Aurora B activity in
KNL1-depleted cells. (A) Schematic of the localization of CB-INCENP and HP1-Survivin chimeras
(top) and schematized experimental procedure (bottom). (B) Line-scans of sister kinetochore pairs from
HeLa cells expressing CB-INCENP or HP1-Survivin and immunostained with the indicated antibodies.
Line scans show the fluorescence intensity across sister kinetochores for a pan-antibody to Aurora B
(AIM1) or Aurora B pT232 antibody and the kinetochore markers Bub1 or KNL1. Line-scans represent
the average position of at least 30 kinetochores per condition. Scale bars, 0.5 mm. (C-E) Normalized
kinetochore fluorescence intensities of control and KNL1-depleted HeLa cells expressing either CB-
INCENP or HP1-Survivin and immunostained with antibodies to Aurora B pT232 (C, D) or Aurora B
(AIM1) (D, E). Scatter plots show intensities at individual kinetochores for Aurora B pT232 or Aurora B
(AIM1) versus GFP intensities of the indicated chimera. (C) shows n≥180 kinetochores from at least 10
cells and 3 independent experiments; (D) shows n≥50 kinetochores from at least 8 cells; (E) shows
n≥180 kinetochores from at least 8 cells and 2 independent experiments. Graphs in (C, E right) represent
the mean and s.d from independent experiments. ***p<0.001, NS= not statistically significantly
different (Mann-Whitney rank sum test). (F) Control and KNL1-depleted HeLa cells expressing CB-
INCENP and immunostained with a Hec1 phospho-specific antibody to Ser44. Fluorescence intensity







Figure 2.14. Aurora B recruitment is not sufficient to restore full Aurora B activity in KNL1-
depleted cells. (A-D) Control and KNL1-depleted HeLa cells expressing either CB-INCENP or HP1-
Survivin and immunostained with antibodies to Aurora B pT232 (A, C) or pan Aurora B (AIM1) (B,






Figure 2.15. Model for KNL1-Mediated Aurora B activation. In early mitosis, phosphorylation of
outer kinetochore substrates relies on Aurora B kinase activity, which is dependent on the N-terminus
of KNL1. KNL1-mediated Bub1 kinase activity enhances Aurora B activation at both the inner
centromere and the kinetochore. Upon generation of stable kinetochore-MT attachments and sister
kinetochore bi-orientation, KNL1 is no longer able to mediate Bub1 kinase activity and Bub1
accumulation, resulting in decreased levels of active Aurora B. During metaphase, reduced levels of
active Aurora B at the kinetochore region[73] lead to further stabilization of kinetochore-MT














KNL1 AS A TOOL TO INVESTIGATE KINETOCHORE ARCHITECTURE AND 




The kinetochore is a network of proteins assembled during mitosis on the centromeric 
region of DNA that functions as the physical link between chromosomes and microtubules 
(MTs). Such physical connection between chromosomes and MTs is an absolute requirement for 
correct chromosome congression to the equator of the cell and final separation of the sister 
chromatids. Therefore, a functional kinetochore is necessary for mitosis fitness. The kinetochore 
protein KNL1 facilitates the localization of several proteins implicated in a wide range of 
kinetochore functions, including checkpoint activation, checkpoint silencing, kinetochore-MT 
attachment stabilization, and kinetochore-MT attachment destabilization. Not surprisingly, loss 
of KNL1 function leads to i) abrogation of kinetochore localization of multiple mitotic proteins 
and ii) perturbation of a variety of mitotic processes, resulting in defective mitotic progression 
and chromosome missegregation.  
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Although there is limited structural information for human KNL1, its predicted lack of 
structure (more than half of the protein) and its multiple binding partners, agree with the notion 
that KNL1 behaves as a scaffold protein [95]. Scaffold proteins generally contain modular 
regions that allow for conformational flexibility and for the establishment of large protein 
networks [96]. Thus, despite their lack of enzymatic activity, these subcellular organizers can 
influence and even regulate signaling pathways, not only by serving as a site where signaling 
takes place, but also by modulating activities of other molecules upon binding and/or by 
temporally regulating the binding of specific proteins. In this regard, KNL1 was recently shown 
to be required for the activities of two important mitotic kinases, Aurora B and Bub1 [44], 
raising the possibility that KNL1 directly influences mitotic regulatory pathways. Requirement 
of KNL1 for the activities of Aurora B, involved in the regulation of kinetochore-MT 
attachment, and Bub1, involved in checkpoint signaling, is an example of how KNL1 may 
integrate different signaling pathways at the kinetochore.  
Despite a central role for KNL1 in defining kinetochore structure and function [95], the 
specific regions of KNL1 that mediate kinetochore localization of many kinetochore proteins 
have not been investigated. Here, we use a set of KNL1 fragments [44] to determine the regions 
of KNL1 involved in the recruitment of a suite of checkpoint-related proteins by 
immunofluorescence. We additionally investigate by proteomics analysis the binding profile of 
KNL1 fragments from human cells. Our results reveal that checkpoint activating and checkpoint 
silencing proteins are recruited to the N-terminal region of KNL1 and demonstrate KNL1 as a 
practical tool to dissect the organization of kinetochore components, and the extent of protein 
dependencies for kinetochore localization. This systematic approach has led to a comprehensive 
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analysis of how KNL1 influences individual signaling pathways during mitosis and will 
contribute to our overall understanding of the complex kinetochore regulatory network. 
 
3.2 Results 
KNL1 KI motifs are sufficient for kinetochore localization of the checkpoint protein BubR1 
Within its N-terminal region, KNL1 contains two KI motifs KI1 and KI2, that directly 
interact with the TPR domains of the checkpoint proteins Bub1 and BubR1, respectively [12, 13, 
21, 22] (Figure 3.1A). In addition, the central and N-terminal regions of KNL1 contain several 
MELT motifs that upon Mps1 phosphorylation directly bind to a Bub3/Bub1 complex [24-26] 
(Figure 3.1B). The KI1/TPR interaction between KNL1 and Bub1 is not sufficient for Bub1 
accumulation at kinetochores [22,44]. Instead, the phosphorylated MELT motifs on KNL1 act as 
individual binding units that promote and enhance the recruitment of Bub1 [97, 98]. While the 
Bub1 recruitment pathway is now well established, the requirements of KI and/or MELT repeats 
on KNL1 for kinetochore recruitment of BubR1 is not clear, and a flurry of recent papers offers 
no consensus on how BubR1 is recruited to kinetochores [97, 98, 99]. Zhang et al. found that 
MELT repeats are sufficient to mediated BubR1 kinetochore accumulation [98], and an 
engineered KNL1 construct lacking the KI motifs, but containing modules of MELT repeats and 
a kinetochore localization domain was able to mediate BubR1 kinetochore accumulation [97]. 
On the other hand, Vleugel et al. found that LacI-arrays of a fragment of KNL1 containing both 
KI motifs and one MELT repeat (KNL1 250N), was able to mediate accumulation of BubR1 at 
the LacI-LacO site, and mutations of any of these three motifs abolished BubR1 recruitment 
[98]. In agreement with this result, Krenn et al. showed that purified BubR1 binds to KNL1 
250N specifically with intact KI motifs, and that KNL1 250C co-immunoprecipitates with 
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BubR1 from cells [99]. In contrast, however, Vleugel et al. reported that KNL1 250N was not 
able to mediate recruitment of BubR1 at kinetochores [98]. Therefore, the significance of the KI 
motifs for BubR1 localization needs to be confirmed in a consistent kinetochore background. For 
this purpose, we tested which of our HeLa cell lines stably expressing KNL1 fragments [44], that 
differ in the presence and number of KI and MELT motifs, were able to mediate BubR1 
kinetochore recruitment (Figure 3.1A).  
In agreement with two of the three recent studies [97, 98], we detected BubR1 at 
kinetochores in cells depleted of endogenous KNL1 and expressing 300-800N KNL1, which 
contains several MELT repeats, but is missing the KI motifs. Furthermore, we did not detect 
BubR1 in cells expressing KNL1 C-terminal fragments (1200C), which only contains one MELT 
repeat (Figure 3.2A). Therefore, as concluded by Zhang et al. and Vleugel et al., modules of 
MELT repeats, which enhance accumulation of Bub1 (and Bub3) at kinetochores, are sufficient 
to mediate BubR1 kinetochore recruitment [97, 98]. Contrary to the Vleugel et al. study [98], 
however, we were able to detect BubR1 in cells depleted of endogenous KNL1 and expressing 
300N KNL1, which, similar to 250N KNL1 [97, 99], contain both KI motifs and two MELT 
repeats (Figure 3.2B). BubR1 was detected in 300N KNL1 cells by both immunofluorescence 
(data not shown) and by expression of a BubR1-mCherry construct (Figure 3.2B). When 
compared to 300-800N KNL1, 300N KNL1 expressing cells exhibit BubR1 localization, albeit at 
low levels (data not shown). It is possible that the two MELT repeats contained in 300N KNL1 
mediates low levels of BubR1 localization. However, based on previous evidence demonstrating 
the relevance of the KI motifs for BubR1 binding to KNL1 250C, our results indicate that both 
the KI motifs and MELT repeats are sufficient, individually, to mediate BubR1 accumulation, 
although at different levels.  
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Kinetochore localization of the checkpoint proteins Mad1 and Mad2 is MELT-dependent 
The current model for checkpoint activation during mitosis suggests that kinetochore 
accumulation of Mad1 and Mad2 is a required step for the amplification of the inhibitory signal 
that prevents anaphase onset and mitotic exit [9]. Mad1 allows for Mad2 kinetochore recruitment 
by direct binding [6, 8, 9, 56], and recently, it was demonstrated that Bub1/Bub3 are the main 
receptors for Mad1/Mad2 at yeast kinetochores [100]. Previous studies in mammalian cells have 
also implicated Bub1 as an essential factor for Mad1/Mad2 accumulation, along with the Ndc80 
complex, and the RZZ complex [7-9, 27]. We asked whether the dependence of Mad1/Mad2 on 
KNL1 for kinetochore localization followed a similar localization pattern to that of Bub1 in 
human cells.  We generated Mad1 and Mad2 constructs tagged with mCherry at their N-terminus 
and overexpressed them in HeLa cell lines depleted of endogenous KNL1 and expressing 
different GFP-tagged KNL1 fragments. In agreement with the localization pattern observed for 
Bub1 [44], Mad1 and Mad2 accumulated in control cells and also in cells expressing KNL1 
fragments that contained multiple MELT repeats (300-800N, 1500C) but did not accumulate in 
cells expressing KNL1 fragments lacking MELT repeats (800C) or containing only 1-2 MELT 
repeats (300N, 1200C) (Figure 3.3A and 3.3B). Our results demonstrate that Mad1/Mad2 
accumulation at human kinetochores requires the presence of MELT-repeats modules and 
follows Bub1 localization. 
 
The checkpoint-related RZZ components localize to KNL1 N-terminus 
The RZZ complex, formed by Zwilch, Zw10, and Rod, functions as a receptor for the 
protein Spindly, which directly recruits the dynein-dynactin complex to kinetochores [52, 54]. 
The motor protein dynein is responsible for stripping of Mad1/Mad2 from kinetochores after MT 
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attachment and subsequent silencing of the checkpoint [101, 102]. Interestingly, components of 
the RZZ complex have also been implicated in kinetochore recruitment of Mad1 and Mad2 [103, 
104]. As for Mad1 and Mad2, kinetochore localization of the RZZ components depends on 
KNL1 [42]. Despite these dependencies, there is no evidence for direct interaction between RZZ 
components and Mad1/Mad2, Bub1, BubR1, or KNL1. It is known, however, that the RZZ 
component Zw10 directly interacts with Zwint1, a protein that directly binds to the C-terminal 
region of KNL1 and exhibits interdependency with KNL1 for kinetochore localization [42, 52, 
105] (Figure 3.1A). Because Zwint1 directly interacts with Zw10, and its depletion causes as 
significant reduction of RZZ components, it has been assumed that Zwint1 is the primary 
kinetochore receptor for the RZZ complex [104], and that the Zwint1/RZZ pathway is directly 
involved in Mad1/Mad2 recruitment. Recent data from yeast, however, demonstrates that 
Bub1/Bub3 directly interact with Mad1, and Bub1/Bub3 localization is a required step for 
Mad1/Mad2 kinetochore accumulation [100]. In addition, a recent study in human cells showed 
that Zwint1 depletion partially reduces KNL1 and RZZ components at kinetochores to similar 
levels (~60%), while KNL1 depletion completely abolishes both Zwint1 and RZZ kinetochore 
localization [42]. These results suggest that RZZ components may rely on a Zwint1-independent, 
KNL1-mediated pathway for kinetochore localization. To determine the region of KNL1 
sufficient to recruit RZZ components to kinetochores and to assess whether localization of RZZ 
correlates with Zwint1, we analyzed the kinetochore recruitment of both Zwint1 and RZZ 
components in our FlpIn HeLa stable cell lines. As shown in Figure 3.4A, only cells expressing 
the C-terminal KNL1 fragments 1500C, 1200C and 800C, which contain the Zwint1 binding 
region (aa 1834-2107), were able to mediate Zwint1 recruitment. As expected, the minimal 
KNL1 C-terminal region (2056-2316) required for KNL1 kinetochore localization and contained 
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in 300N and 300-800N KNL1, was not able to mediate Zwint1 recruitment (Figure 3.4B). In 
contrast, KNL1 300N, 300-800N, and 1500C, were sufficient to drive kinetochore accumulation 
of the RZZ components (Figure 3.5A and 3.5B). Surprisingly, these results show that the RZZ 
complex does not follow the localization pattern of Zwint1, but instead, it follows a similar 
localization pattern as BubR1, in which MELT enrichment is sufficient but not necessary for 
localization. It is possible that, at wild-type kinetochores, the RZZ complex localizing proximal 
to Bub1/Bub3, helps in the recruitment of Mad1/Mad2. Whether direct interaction between 
Zw10 and Zwint1, either at the kinetochore or in the cytoplasm, is required for RZZ localization 
to the KNL1 N-terminus remains to be tested. Regardless, these data demonstrate that Zwint1 
kinetochore localization is not sufficient or necessary for RZZ recruitment. 
 
Proteomics analysis of KNL1 fragments reveals positioning of known kinetochore proteins 
and uncharacterized kinetochore proteins  
KNL1 functions as a spatial coordinator of multiple kinetochore protein complexes that 
direct the signaling events required for correct segregation of chromosomes during mitosis. 
Identifying the repertoire of KNL1 binding partners, and the regions of KNL1 involved in such 
interactions, are key for the understanding of kinetochore architecture and its activities. Aiming 
for a comprehensive view of the kinetochore network, with KNL1 as a central player, we 
generated inducible 293T cells stably expressing Flag-tagged KNL1 fragments for proteomics 
analysis (Figure 3.6A and 3.6B). Specifically, we immunoprecipitated Flag-tagged 300N, 300-
800N and 1500C KNL1 after synchronization, nocodazole treatment, and doxycycline induction, 
and performed LC-MS/MS analysis to determine the binding profiles of the different KNL1 
regions (see Methods for details). We used FlpIn 293T host cells lysates as control. As expected, 
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the KNL1 peptides identified by LC-MS/MS on each sample or cell line corresponded to the 
region of the protein expressed by each cell line (Figure 3.7A). We used the normalized spectral 
abundance factor (NSAF) as an estimate reference of the relative abundance of KNL1 in each 
sample, and we found highly similar values between them, indicating that we 
immunoprecipitated the KNL1 fragments (300N, 300-800N, 1500C) at similar levels, and 
therefore, differences in protein binding profiles between them are likely independent of KNL1 
abundance (Figure 3.6B).  Importantly, the NSAF values used here are only an approximation of 
relative abundance and precise quantitative values need to be determined by comparing samples 
across multiple experiments.   
 Although only 12 known kinetochore proteins were identified in all samples, several of 
them corresponded to the cell lines expressing the regions of KNL1 known to mediate their 
localization (Figure 3.7A and 3.7B). For instance, components of the Ndc80 were identified in 
all samples (the three KNL1 fragments contain a short C-terminal region for kinetochore 
binding; see Figure 3.1A). Similarly, the phosphatase PP1, known to interact with the SILK and 
RVSF motifs in the far N-terminal region of KNL1 [20], was only identified in 300N KNL1 
(Figure 3.8A). Furthermore, although tubulin was detected in all samples, including the control, a 
3-fold higher NSAF value was found for 300N KNL1, the fragment that contains the KNL1 MT 
binding domain (data not shown) [28, 29]. 
In addition to previously mapped kinetochore proteins, we identified some centromere 
and kinetochore proteins whose precise kinetochore localization mechanism is unknown, such as 
Aurora B kinase, INCENP and dynein (Figure 3.8A and 3.8B) (see discussion below). Moreover, 
previously unidentified proteins were differentially found across KNL1 fragments (Table 3.1 and 
3.2). From this list of “new” kinetochore proteins, Poly (ADP-ribose) polymerase-1 (PARP-1), 
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comes to our attention.  PARP1 catalyzes polyADP-ribosylation of proteins, and is involved in 
the DNA damage response [106].  Interestingly, however, a previous report demonstrated that 
PARP1 co-immunoprecipitates with its functional homolog PARP2 and with the kinetochore 
proteins CenpA, CenpB and Bub3, suggesting a possible role for PARP1 during mitosis [107]. It 
will be interesting to confirm whether PARP1 is observed at kinetochores, and to determine its 
localization pattern on KNL1 by other means.  
Together, our results establish proteomics analysis of different KNL1 mutants as a 
practical approach to evaluate kinetochore architecture in cells.  
 
3.3 Discussion 
Unraveling the composition and organization of the kinetochore is an essential task to 
understand how kinetochore proteins coordinate mitotic processes. As a central kinetochore 
scaffold, KNL1 functions as an integrator of kinetochore activities, and exploring the details 
regarding KNL1 interactions will provide much-needed insights into the regulatory processes 
occuring at the kinetochore. Here, we mapped the kinetochore localization of six known 
checkpoint-related proteins and the kinetochore protein Zwint1, using a HeLa cells stably 
expressing a suite of KNL1 fragments. While Zwint1 localized to the C-terminal region of 
KNL1, all checkpoint-related proteins localized to the N-terminus of KNL1.  
Since the discovery of MELT repeats at the N-terminal and central regions of KNL1, 
Bub1 and Bub3 have been the only proteins shown to have physical association with these 
regions of KNL1 [24, 26]. In addition, it has been clearly demonstrated that MELT-rich regions 
enhance the accumulation of Bub1 (and presumably Bub3) at kinetochores, and they are 
mutually dependent for this interaction [24, 26, 44, 97, 98]. In contrast, the KI motifs on KNL1 
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are not sufficient for Bub1 kinetochore accumulation [44]. Bub1 was recently demonstrated to be 
a kinetochore receptor for Mad1 and Mad2 in yeast [100]. In agreement with this, we find that 
Mad1/Mad2 localization perfectly matches with Bub1 localization in human cells. Bub1 has also 
been shown to be required for BubR1 kinetochore localization [43], however, direct interaction 
between Bub1 and BubR1 has not been reported. Instead, Bub1 and BubR1 directly bind to the 
checkpoint protein Bub3, and in both cases, it is proposed that binding to Bub3 is required for 
their kinetochore localization [48]. From our KNL1 mapping analysis, we find that BubR1 
accumulates at kinetochores in cells expressing both MELT-rich KNL1 fragments and KI-
containing KNL1 fragments (300N). We previously reported that 300N KNL1 is not able to 
mediate Bub1 kinetochore accumulation [44]. A more recent study, however, reports that a 
similar KNL1 construct (250N KNL1) immunoprecipitates Bub1 and Bub3, and mediates low 
levels of Bub1 recruitment at kinetochores, suggesting that although not accumulated at high 
levels, Bub1 interacts with the far N-terminal region of KNL1 in the absence of multiple MELT 
repeat modules [99]. Together, these data suggest that BubR1 accumulation depends on the 
Bub1/Bub3/KNL1 interaction. Specifically, MELT-rich KNL1 fragments mediate BubR1 
recruitment in absence of KI motifs due to their ability to accumulate Bub1/Bub3 at high levels. 
On the other hand, transient interactions between Bub1/Bub3 and 300N KNL1 (Bub1 interacting 
through the KI1 motif and Bub3 interacting through two MELT repeats), likely stabilizes the 
BubR1/KNL1 interaction (Figure 3.9). However, since Bub1/Bub3 do not highly accumulate at 
kinetochores in the absence of MELT repeats, low levels of BubR1 are also observed at 
kinetochores in cells expressing 300N KNL1. Based on the fact that Bub1 does not bind BubR1, 
but both proteins directly interact with Bub3, and Bub1/Bub3 are mutually dependent for 
interaction with the MELT repeats on KNL1, we propose a model in which BubR1 kinetochore 
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localization depends directly on Bub3 and indirectly on Bub1 accumulation (Figure 3.9). Further 
experiments are needed to corroborate this model. It remains to be tested whether a 300N KNL1 
fragment containing mutations in the KI2, and/or the MELT motifs, abolish BubR1 kinetochore 
recruitment. Also, the use of a Bub3 mutant unable to bind the phosphorylated MELT repeats 
will disrupt Bub1 enrichment at kinetochores, and it will allow us to test whether Bub1/Bub3 
recruitment is a requirement for BubR1 kinetochore localization (see Future Experiments).  
Similar to the pattern observed for BubR1, the RZZ components Rod, Zwilch and Zw10 
(data not shown), showed localization to both MELT-rich regions and KI-containing regions of 
KNL1. Although it is not clear what drives the accumulation of the RZZ components Zwilch, 
Rod and Zw10 to these regions of KNL1, the fact that both the MELT-rich regions and the KI-
containing regions are sufficient for RZZ complex kinetochore accumulation, raises the 
possibility that the Bub1/Bub3/BubR1 complex may serve as the kinetochore receptor for RZZ 
(see Future Experiments) (Figure 3.9). In vitro binding assays and structural studies will be 
determinant in unraveling how the N-terminal region of KNL1 modulates interactions with 
checkpoint activating proteins such as Mad1, Mad2, Bub3 and BubR1 and also with proteins 
implicated in checkpoint silencing such as the RZZ complex and the phosphatase PP1.  
Results from proteomics analysis with our different KNL1 mutants support the notion 
that expression of KNL1 modules in cells can provide us relevant information about kinetochore 
architecture. In addition, the identification of kinetochore-localized proteins previously 
unconsidered will undoubtedly provide a broader view of the kinetochore network. We identified 
several kinetochore proteins expected to immunoprecipitate with specific KNL1 regions. For 
instance, we found the phosphatase PP1 only in samples from cells expressing the 300N region 
of KNL1, where the PP1 binding motifs are contained [20], and Zwint1, in cells expressing 
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1500C KNL1, the only fragment that contained an intact Zwint1 binding domain (Figure 3.8A). 
Similarly, components of the Mis12 and Ndc80 complexes, known to reside at the C-terminal 
region of KNL1, were found in all our KNL1 mutants. These results demonstrate that proteomics 
analysis serves as a precise and complimentary tool to map kinetochore proteins.  
An interesting finding from our proteomics data is the identification of Aurora B kinase 
and INCENP in cells expressing 300-800N KNL1 (Figure 3.8A). We recently demonstrated that 
the KNL1 N-terminus is required for Aurora B kinase activity at kinetochores. In the model that 
we envision, KNL1 and Bub1 directly influence the activation of Aurora B, independent of 
Aurora B accumulation at the inner centromere [44]. In such a model, however, it is not clear 
how activation occurs.  A reasonable hypothesis is that Aurora B is recruited to the kinetochore 
region where the KNL1 N-terminus directly promotes its activation.  We previously tested this 
through binding assays using purified components (data not shown), however, we did not find a 
direct interaction between the KNL1 N-terminus and Aurora B kinase. Our proteomics results 
raise the possibility that the KNL1 N-terminus indirectly mediates the localization of Aurora B 
and its primary activator, INCENP, to the kinetochore region (possibly via Bub1). Further 
analyses are necessary to determine how these interactions may be occurring. Also, optimization 
of KNL1 immunoprecipitations for use in proteomics experiments will be required to identify a 
larger number of kinetochore proteins and to provide a detailed map of the kinetochore network.  
In summary, our data show that mapping of kinetochore proteins from cells expressing different 
KNL1 modules, by complementary tools like immunofluorescence and proteomics, provides a 






Cell culture and transfection 
HeLa (ATCC) and FlpIn T-REx HeLa cell lines were cultured in DMEM (Invitrogen), 
supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in 5% CO2. For silence 
and rescue experiments, stable cell lines were doubly blocked with thymidine, depleted of 
endogenous KNL1 using the corresponding siRNAs (described in Caldas et al. 2013 [44]), and 
induced with doxycycline for overexpression. Briefly, cells were transfected with siRNA, 8h 
later treated with 2.5 mM thymidine for 16 h, washed with PBS, replaced with fresh medium, 
transfected with siRNA, and incubated for 8 h. Cells were treated with doxycycline (1µg/ml) for 
induction, and for the second block, 2.5 mM thymidine was added for 16 h. Cells were then 
washed with PBS, replaced with fresh medium containing doxycycline (1µg/ml), and fixed after 
10 h for immunostaining. For all experiments, cells were plated to be 60% confluent at the time 
of transfection on acid-washed glass coverslips. siRNA transfections were performed using 
Oligofectamine (Invitrogen), according to the manufacturer’s instructions. DNA transfections 
were performed using Effectene (Qiagen), using 0.3 µg of plasmid and according to 
manufacturer’s intructions. DNA transfections were performed 6-7h after the first siRNA 
transfection and prior the first thymidine block. 
The FlpIn T-REx 293T host cell line was a gift from T. Yao (Colorado State University, 
Fort Collins, Colorado, USA). To generate FlpIn T-REx 293T cells containing KNL1 fragments 
fused to HA-Flag-Flag at the N-terminus, Flp-In T-REx 293T host cells were co-transfected with 
a ratio of 9:1 (wt/wt) pOG44:pcDNA5/FRT/TO expression plasmid using Fugene HD 
(Promega). 48 h after transfection, cell lines were placed under selection with 100 µg/ml 
hygromycin (EMD Millipore) for 2 wk. Hygromycin-resistant foci were chosen, expanded, and 
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tested for expression by western blot with anti-Flag antibodies. Gene expression was induced 
with 1 µg/ml doxycycline (Sigma-Aldrich) for 24 h. For immunoprecipitation, Host 293T cells 
and each stable cell line were grown on six 150mm tissue culture dishes, doubly blocked with 
thymidine and induced with doxycycline for 24h.  
 
Plasmids 
Mad1, Mad2, and BubR1 were cloned into a pmCherry-C1 plasmid to generate Cherry-
Mad1, Cherry-Mad2, and Cherry-BubR1. All plasmid DNAs were purified using an Endo-free 
Maxi kit (QIAGEN) before transfection. HA-flag-flag 1–300 (300N), 300–818 (300–800N), and 
819–2316 (1500C) KNL1 were generated by PCR using KNL1 wild-type as the template [74] 
and cloned into the pcDNA5/FRT/TO vector using In-Fusion cloning (Clontech).  
 
Immunofluorescence 
 Fixation and immunostaining of HeLa cells were performed as described previously [44]. 
In brief, cells were rinsed in 37°C PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 
and 4 mM MgSO4, pH 6.9), fixed in in 4% paraformaldehyde for 20 min, and extracted in 
PHEM buffer + 0.5% Triton X-100 for 5 min. Immunostaining was performed using the 
following antibodies: rabbit polyclonal anti-Zwint1 (Gene Tex) was used at 1:200; rabbit 
polyclonal anti-Zwilch, provided by D. Varma but originally obtained from A. Musacchio (Max 
Planck Institute of Molecular Physiology, Dortmund, Germany) was used at 1:200; rabbit 
polyclonal anti-Zw10, provided by D. Varma but originally obtained from R. Vallee (Columbia 
University, New York, NY), was used at 1:200; rabbit polyclonal anti-Rod, provided by D. 
Varma but originally obtained from G. Chan (University of Alberta, Edmonton, Alberta, 
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Canada), was used at 1:200; human anti-centromere antibody (ACA; Antibodies, Inc.) was used 
at 1:500; and mouse anti-BubR1 (EMD Millipore) was used at 1:500. Secondary antibodies 
conjugated to either Alexa 647, or Rhodamine Red-X (Jackson ImmunoResearch Laboratories, 
Inc.) were used at 1:300.  
 
Image acquisition and analysis 
Image acquisition was performed on an imaging system (DeltaVision Personal DV; 
Applied Precision) equipped with a camera (CoolSNAP HQ2; Photometrics/Roper Scientific), a 
60×/1.42 NA PlanApochromat objective (Olympus), and SoftWoRx acquisition software 
(Applied Precision). Images were acquired at room temperature as Z-stacks at 0.2-µm intervals.  
 
Immunoprecipitation and Proteomics analysis. 
Cells were carefully washed with PBS twice, scraped from dishes with PBS and 
centrifuged at 1000rpm for 4min. Pellets were frozen at -80⁰C until needed. For 
immunoprecipitation, cells were lysed in lysis buffer (75 mM Hepes, pH 7.5, 150 mM KCl, 1.5 
mM EGTA, 1.5 mM MgCl2, 0.1% NP-40, Complete protease inhibitor cocktail [Roche], and 
PhosSTOP phosphatase inhibitors [Roche]), passed through a 25 gauge needle several times and 
incubated on ice for 30 minutes. Lysates were clarified by centrifugation at 14000rpm for 10 min 
and total protein concentration was measured by BCA assay. Lysates were normalized and 2mg 
of total protein for each sample was used for immunoprecipitation. Normalized lysates were 
incubated with anti-Flag  M2 magnetic beads (Sigma) for 2 h at 4°C. The unbound fraction was 
recovered and beads were washed with lysis buffer (3X). Interacting proteins were eluted by 
competition with 3XFlag peptide twice for 30min at 4°C.  
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Following acetone precipitation, the protein pellet was incubated with 15ul of 8M Urea 
and bath sonicated for 5min for denaturation. Then, 20 ul of 0.2% ProteaseMAX Surfactant 
(Promega) was added and the solution was mixed by shaking for 5min. 50mM Ammonium 
bicarbonate was added, followed by 1 ml of 0.5M DTT and incubated at 50⁰C for 20min. 
Proteins were alkylated with 2.5 ml of 0.55M Iodoacetamide and incubated in the dark for 15 
min at room temperature. Finally, proteins were digested by adding 1 ul of 1% ProteaseMax and 
18 ul of 0.1 ug /ul trypsin and incubating for 3hr at 37⁰C. The reaction was stopped with TFA to 
a final concentration of 0.5%. Peptides were desalted and concentrated using C18 Spin Columns 
(Thermo Scientific 5um, 100 um ID x 2cm C18 column) and then resuspended in Buffer A (3% 
ACN, 0.1% TFA) at a concentration of 1 ug/ul (45 mM) for analysis via LC-MS/MS. 
Chromatographic separation was performed on a reverse phase nanospray column (Thermo 
Scientific EASYnano-LC, 3um, 75 um ID x 100mm C18 column) using a 90 minute linear 
gradient from 10%-30% buffer B (100% ACN, 0.1% formic acid) at a flow rate of 400 
nanoliters/min.   Peptides were eluted directly into the mass spectrometer (Thermo Scientific 
Orbitrap Velos) and spectra were collected over a m/z range of 400-2000 Da using a dynamic 
exclusion limit of 2 MS/MS spectra of a given peptide mass for 90 s. Compound lists of the 
resulting spectra were generated using Xcalibur 2.2 software (Thermo Scientific) with a S/N 
threshold of 1.5 and 1 scan/group.  
All MS/MS samples were searched against the uniprot_hum_rev_102513 database 
(176756 entries) using Mascot (Matrix Science, London, UK; version 2.3.02). The search was 
carried out with a fragment ion mass tolerance of 0.80 Da and a parent ion tolerance of 20 PPM. 
Carbamidomethyl of cysteine was specified as a fixed modification and oxidation of methionine 
was specified as a variable modification. Protein identification results were compiled and 
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validated using Scaffold v.4.3.2 (version Scaffold_4.3.2, Proteome Software Inc., Portland, OR). 
Peptide identifications were accepted if they could be established as greater than 95.0% 
probability by the Scaffold Local FDR algorithm. Protein identifications were accepted if they 
could be established at greater than 99.9% probability and contained at least 2 identified 
peptides.  
 
3.5 Future Experiments and Experiments in Progress: 
 We generated a Bub3-mCherry construct to map the localization of Bub3 in the KNL1 
mutants set and we are generating an Mps1-mCherry construct for similar purposes. With 
these two proteins we will have the reagents to map the KNL1-dependent kinetochore 
recruitment of all of the essential checkpoint proteins.  
 We are generating 300N KNL1 constructs containing mutations in the KI2 motif, the MELT 
motif (already completed), and both, to determine whether localization of BubR1 in 300N 
KNL1 is MELT and/or KI2 dependent. Additionally, we are designing Bub3 constructs 
containing mutations that disrupt Bub3-pMELT interaction (Bub3 disrupted MELT binding 
domain or Bub3-dMELTBD). Using this mutant, we aim to test whether BubR1 localization 
depends on Bub3/KNL1 interaction.  
 In order to have a better understanding of the RZZ, Mad1/Mad2 and Bub1/Bub3/BubR1 
dependencies, we are planning to carry out the following experiments: 
o Depletion of endogenous KNL1 and BubR1 followed by induction of 300-800N KNL1 
expression, to assess whether the RZZ complex localizes to this region of KNL1 in the 
absence of BubR1. We will repeat the same experiment in 300N KNL1 expressing cells. 
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o Depletion of endogenous KNL1 and RZZ components (Zw10 and Zwilch independently) 
or Zwint1, followed by induction of 300-800N KNL1 expression, to assess whether 
Mad1/Mad2 localizes to this region of KNL1 in the absence of the RZZ or in the absence 
of Zwint1.  
 Using our KNL1 mutant cell lines, we have generated a partial KNL1 dependency map for 
the proteins CenpE and CenpF, and we aim to complete these experiments and include them 
in the final manuscript. 
 We will repeat the proteomics experiments using the 293T FlpIn cells expressing the KNL1 
mutants. 
 
Figure 3.1. KNL1 domain architecture. (A) (upper) Representation of human KNL1 and all regions
known to mediate protein interactions. MELT repeats initially identified by Yamagishi et al. 2012 [26]
are shown in gray (MELT repeats reported in Caldas et al. 2013 [44]), and MELT repeats recently
identified by Krenn et al. 2014 [99] and Vleugel et al. 2013 [97] are shown in light blue. (lower)
Schematic of GFP-KNL1 constructs stably incorporated into Flp-In T-REx HeLa cell lines (Caldas et al.
2013 [44]); the amino acids of KNL1 constructs shown are as follows: amino acids 1-300 (300N), 300-
818 (300-800N), 1174-2316 (1200C) 1519-2316 (800C), 819-2316 (1500C), 2056-2316 (C). (B)
Alignment of MELT repeats in human KNL1, adapted from Krenn et al. 2014 [99]. The new consensus
sequence for MELT repeats is [M/I/L/V]-[E/D]-[M/I/L/V]-T [99]. The yellow box indicates the MELT
repeats not included in our KNL1 1500C construct (aa 910–1120 are not contained in the wild-type





Figure 3.2. KNL1-mediated localization pattern of BubR1. (A-B) Flp-In T-REx HeLa cells were
depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon doxycycline
addition and immunostained with an antibody against BubR1 (A), or overexpression of a BubR1-
mcherry construct was carried out (B). (A) Representative cells are shown, n ≥15 cells for each condition





Figure 3.3. KNL1-mediated localization pattern of Mad1 and Mad2. (A-B) Flp-In T-REx HeLa cells
were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon doxycycline
addition and overexpression of a Mad1-mcherry or Mad2-mcherry construct was carried out. (B)
Percentage of cells with detectable levels of fluorescent Mad1-mcherry or Mad2-mcherry were scored as
positive; n ≥50 for each construct or condition evaluated.
BA
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Figure 3.4. KNL1-mediated localization pattern of Zwint1. (A-B) Flp-In T-REx HeLa cells were
depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon doxycycline (A),
or by transient overexpression (B) and immunostained with an antibody against Zwint1. (B) 400C
indicates amino acids 1834-2316 of hKNL1; 200C indicates amino acids 2016-2316 of hKNL1. (A,B)




Figure 3.5. KNL1-mediated localization pattern of RZZ components. (A-B) Flp-In T-REx HeLa
cells were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon
doxycycline addition and immunostained with the indicated antibody; Rod (A); Zwilch (B). (A,B)








































Figure 3.6. Flag-tagged KNL1 fragments used for proteomics analysis. (A) (upper) Schematic of the
Flp-In T-REx 293T stable cell lines used for proteomics; (lower) protocol followed for collection of cell
pellets for proteomics. (B) KNL1 expression of Flp-In T-Rex 293T cells stably expressing Flag-tagged
KNL1 fragments were analyzed by Western blotting; cells were not induced (NI), induced with
doxyxyxline and analyzed after 24h, or after 48h. Tubulin and actin are shown as loading controls. (C)
Eluted samples after small scale immunoprecipitations of not induced (-Dox) or induced (+Dox) Flag-
tagged KNL1 fragments were analyzed by Western blot.
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300N KNL1
Peptides between aminoacids 58-246:
300-800N KNL1
Peptides between aminoacids 366-799:
1500C KNL1
Peptides between aminoacids 1432-2090:
Figure 3.7. KNL1 peptides identified by mass spectrometry. (A) the KNL1 peptides identified in
each 293T cell line stably expressing KNL1 fragments are shown. (B) Normalized Spectral Abundance
Factor (NSAF) for KNL1 in each 293T cell line analyzed is shown.
A
Host 300N 300-800N 1500C
KNL1 
(NSAF)
0 0.0115 0.0111 0.0091
B
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Figure 3.8. Known kinetochore proteins identified by proteomics. (A) Table showing the set of
kinetochore and centromeric proteins identified by mass spectrometry on each KNL1 fragment. (B)
Schematic showing the KNL1 fragments analyzed by mass spectrometry and the location of the proteins
identified.
Host 300N 300-800N 1500C
Hec1 - + + -
Nuf2 - + + -
Spc24 - + + +
Spc25 - + + +
Nsl1 - + + +
Mis12 - + + -
Dsn1 - + + -
PP1 - + - -
Dynein - + + +
Aurora B - - + -
INCENP - - + -




Table 3.1. New kinetochore proteins identified by proteomics analysis. Table showing the proteins
identified by proteomics analysis, not previously reported to be at the kinetochore region or known to be
dependent on KNL1 for kinetochore localization.
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PROTEIN ID HOST 300N 300-800N 1500C
Isoform 2 of DnaJ homolog subfamily A member 1 OS=Homo sapiens GN=DNAJA1 - + - -
Isoform 2 of Mitochondrial import inner membrane translocase subunit TIM50 OS=Homo sapiens GN=TIMM50 - + - -
26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=2 SV=1 - + - -
Isoform 2 of ATP-dependent RNA helicase DDX3X OS=Homo sapiens GN=DDX3X - + - -
Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 - + - -
Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2 - + + -
Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 - + + -
THO complex subunit 4 OS=Homo sapiens GN=ALYREF PE=2 SV=1 - - + -
Proteasome subunit beta type-3 OS=Homo sapiens GN=PSMB3 PE=1 SV=2 - - + -
Isoform 2 of Polyamine-modulated factor 1 OS=Homo sapiens GN=PMF1 - - + -
Isoform A2 of Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens GN=HNRNPA2B1 - - + -
Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens GN=SUB1 PE=1 SV=3 - - + -
ELKS/Rab6-interacting/CAST family member 1 OS=Homo sapiens GN=ERC1 PE=2 SV=1 - - - +
Table 3.2. Unique peptides and sequence coverage of newly identified kinetochore protein. Table
showing the number of unique peptides and sequence coverage for proteins identified by proteomics
analysis, not previously reported to be at the kinetochore region or known to be dependent on KNL1 for
kinetochore localization.
PROTEIN ID HOST 300N 300-800N 1500C
Isoform 2 of DnaJ homolog subfamily A member 1 OS=Homo sapiens GN=DNAJA1 - 2(13%) - -
Isoform 2 of Mitochondrial import inner membrane translocase subunit TIM50 OS=Homo sapiens GN=TIMM50 - 3(9%) - -
26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=2 SV=1 - 2(5%) - -
Isoform 2 of ATP-dependent RNA helicase DDX3X OS=Homo sapiens GN=DDX3X - 2(5%) - -
Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 - 11(14%) - -
Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2 - 2(4%) 2(3%) -
Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 - - 13(20%) -
THO complex subunit 4 OS=Homo sapiens GN=ALYREF PE=2 SV=1 - - 3(27%) -
Proteasome subunit beta type-3 OS=Homo sapiens GN=PSMB3 PE=1 SV=2 - - 2(17%) -
Isoform 2 of Polyamine-modulated factor 1 OS=Homo sapiens GN=PMF1 - - 4(34%) -
Isoform A2 of Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo sapiens GN=HNRNPA2B1 - - 2(9%) -
Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens GN=SUB1 PE=1 SV=3 - - 2(19%) -




but is dispensable for 
Bub1 accumulation
KI2 is important for BubR1 
binding, and although it is 
dispensable for BubR1 
accumulation, it is also 
sufficient to drive partial 
BubR1 kinetochore 
accumulation in the absence 
of multiple MELT modules.
MELT repeats on KNL1 
enhance accumulation of 
Bub1 and Bub3. Bub3 binds 
to both Bub1 and BubR1 at 
the same region (GLEBS). 
MELTS are necessary and 
sufficient to drive Bub1 
kinetochore accumulation. 
MELTS are sufficient to drive 
BubR1 kinetochore 
accumulation.
Figure 3.9. Model of KNL1 binding profile at its N-terminal region. Representaion of human KNL1
and its known motifs residing at the N-terminus of the protein. KI1 motif, shown in red, interacts with
Bub1. KI2 motif, shown in blue, interacts with BubR1. MELT motifs, shown in gray, interact with
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We recently demonstrated that the N-terminal region of KNL1 is necessary and sufficient 
for Aurora B-mediated regulation of kinetochore-MT attachments [44]. In addition, we and 
others confirm that the N-terminal half of KNL1, which contains the MELT and MELT-like 
repeats, is also sufficient for accumulation of the checkpoint-related proteins Bub1, BubR1, 
Mad1/Mad2 and RZZ components (see Chapter 3). Since the N-terminal region of KNL1 is able 
to both mediate activity of the principal error correction mechanism regulator (Aurora B) and 
mediate accumulation of critical checkpoint components, we asked whether the KNL1 N-
terminus was sufficient for correct mitotic progression.  
 
A1.2 Results and Discussion 
Depletion of KNL1 causes chromosome misalignment and missegregation in several 
organisms [95]. We quantified the level of chromosome misalignment in metaphase in cells 
depleted of endogenous KNL1 and rescued with our set of KNL1 fragments. In agreement with 
Vleugel et al., depletion of KNL1 caused severe chromosome misalignment (quantified as cells 
with no discernable metaphase plate or cells with one or more chromosomes off of the 
metaphase plate), and the C-terminal KNL1 fragments (1200C) were not able to recover 
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alignment defects [97] (Figure A1.1A). In contrast, KNL1 fragments containing several MELT 
motifs (300-800N) partially restored alignment defects (Figure A1.1A). Also, in agreement with 
the results reported by Vleugel et al., the 300N fragment (similar to 250N in that study) did not 
restore alignment defects (Figure A1.1A and A1.1C) [97]. We also quantified alignment defects 
in cells treated with MG132, a proteasome inhibitor that arrests cells in metaphase. We found 
that cells expressing MELT-containing KNL1 fragments (300-800N and 1500C) behaved 
similarly with or without MG132 treatment (Figure A1.1A and A1.1B). However, cells 
expressing 300N KNL1 exhibited better alignment upon MG132 treatment (Figure A1.1B). A 
reasonable explanation for this result is that cells expressing 300N KNL1 have the same capacity 
to align chromosomes as cells expressing 300-800N or 1500C KNL1, but alignment to 
metaphase in 300N KNL1 cells takes longer. Importantly, our results indicate that despite its 
ability to recruit checkpoint proteins and mediate Aurora B phospho-regulation, the N-terminal 
region of KNL1 is not sufficient to fully restore the alignment defects observed upon KNL1 
depletion. 
We next analyzed timing through mitosis in cells expressing the KNL1 mutants. The time 
a cell spends in mitosis depends on the time it takes to completely align chromosomes, stabilize 
MT attachments, and also, on the ability of the checkpoint machinery to prevent mitotic exit 
while these processes are occurring. For instance, cells with a functional checkpoint machinery 
but with defective chromosome alignment exhibit a mitotic delay. Similar to the results reported 
by Vleugel et al. we find that 300N and 1200C cells exhibit a significant delay in mitosis, while 
300-800N KNL1 expressing cells had a slight mitosis delay (Figure A1.1D) [97]. Cells 
expressing 300-800N KNL1 cells exhibit alignment defects, but are able to accumulate 
checkpoint proteins at high levels, therefore, a slight delay in mitotic progression is not 
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surprising. Counterintuitively, 300N KNL1 expressing cells, which do not accumulate high 
levels of checkpoint proteins, exhibit a longer delay in mitosis when compared to 300-800N 
KNL1 (Figure A1.1D). One possibility is that the checkpoint in these cells is as robust as in 300-
800N KNL1 expressing cells, but because cells expressing 300N KNL1 take more time aligning 
chromosomes [97], the total time through mitosis is longer. Indeed, Vleugel et al. showed that 
250N KNL1 supports a checkpoint as efficiently as wild-type KNL1 in the presence of 
nocodazole and reversine [97]. Interestingly, KNL1-depleted cells and 1200C expressing cells 
exhibit a significant mitotic delay despite their inability to accumulate checkpoint proteins 
(Figure A1.1D).  Furthermore, KNL1 depleted cells can arrest in mitosis in the presence of 
different doses of nocodazole for at least 6 hours, indicative of a functioning checkpoint (data not 
shown) [98]. Only when the cells are challenged with nocodazole and small amounts of 
reversine, an Mps1 inhibitor, is the checkpoint abrogated in KNL1-depleted cells or cells 
expressing the KNL1 C-terminus [97]. How cells that are unable to recruit checkpoint proteins at 
kinetochores can mediate a mitotic arrest for a significant amount of time (~6h) in presence of 
microtubule poisons is an interesting question that demands further investigation. Perhaps there 
are alternative mechanisms that trigger a mitotic arrest in presence of disrupted spindles and a 
defective checkpoint.  
 
A1.3 Methods 
Cell culture and transfection 
HeLa (ATCC) and FlpIn T-REx HeLa cell lines were cultured in DMEM (Invitrogen), 
supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in 5% CO2. For silence 
and rescue experiments, stable cell lines were doubly blocked with thymidine, depleted of 
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endogenous KNL1 using the corresponding siRNAs (described in Caldas et al. 2013), and 
induced with doxycycline for overexpression (see methods in Chapter 2 and Chapter 3). siRNA 
transfections were performed using Oligofectamine (Invitrogen), according to the manufacturer’s 
instructions. For chromosome alignment analysis, MG132 was used at 5µM for 45min before 
fixation. 
 
Immunofluorescence and Live cell imaging 
Fixation and immunostaining of HeLa cells were performed as described previously [44]. 
For live cell imaging, HeLa cells in 35-mm glass-bottomed dishes (MatTek Corporation) were 
transfected with KNL1 siRNA and induced with doxycycline as described above. Cells were 
imaged in Leibovitz’s L-15 media (Invitrogen) supplemented with 10% FBS, 7 mM Hepes, pH 
7.0, and 4.5 g/L glucose. Stage temperature was maintained at 37°C with an environmental 
chamber (Precision Control). Fluorescence images of GFP-KNL1 expressing cells were acquired 
every 5min for 8-9h.  
 
 
Figure A1.1. Phenotypic analysis of cells containing KNL1 fragments. (A-D) Flp-In T-REx HeLa
cells were depleted of endogenous KNL1, rescued with the indicated GFP-KNL1 fragment upon
doxycycline addition, and analyzed for chromosome alignment (A); chromosome alignment after
MG132 treatment (B,C); or analyzed by live cell imaging (D). (A) Error bar represent standard deviation
between experiments; n=3 independent experiments; n≥50 cells scored per experiment. (C)
representative images of metaphase chromosomes in the indicated conditions. (D) Cumulative frequency













Understanding the function of a particular gene relies on the ability to manipulate it, 
silence it, or make changes to specific regions of the gene in order to investigate the defects that 
such changes may induce in the cell. For this purpose, genome editing tools are ideal, since they 
allow for penetrant modification of the gene of interest in a cell and its progeny.  
Genome editing in mammalian cells was first established in mouse embryonic stem (ES) 
cells, for which, Capecchi, Evans, and Smithies received the Nobel Prize in 2007. Yet, this 
technology has been mainly applied to yeast, chicken DT40 cells, and mouse ES cells [108]. 
Modification of endogenous genes within differentiated human cell types is much less efficient 
than in the mentioned organisms, however, different technologies that allow higher efficiencies 
in genome alteration have arisen. For instance, genome editing using engineered nucleases has 
been demonstrated as a powerful technology that enables manipulation of targeted genes in 
several organisms as well as in highly proliferative human cell lines [107, 108].  
Engineered nucleases permit random or designed genomic modification at precise loci 
through the stimulation of endogenous double-strand break (DSB) repair [107, 108].  Following 
targeted DNA DSB, cellular DNA repair mechanisms including non-homologous end-joining 
(NHEJ) and the homology-directed repair (HDR) are activated. NHEJ is an error-prone repair 
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mechanism that results in insertions and/or deletions (indels) at the target site [110]. HDR on the 
other hand, uses a homologous segment of DNA as a template to repair the damaged DNA and 
therefore, it is assumed to be error free [110]. Thus, when an engineered nuclease that creates a 
DSB in the gene of interest, and a donor DNA containing left and right homology arms flanking 
the breaking site, are introduced into the cell, homologous recombination-mediated 
modifications to the target gene can be achieved.  
To date, there are three main types of customizable nuclease-based gene editing systems, 
zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and 
clustered regularly interspaced short palindromic repeats (CRISPR). They all differ in the 
machinery that guides the binding of the nuclease to a specific DNA sequence. ZFN and 
TALENs are composed of sequence-specific DNA binding domains fused to a nonspecific DNA 
cleavage module [108-110]. The nuclease used in the CRISPR system on the other hand, is 
guided by a molecule of RNA [110]. Compared with TALENs and ZFN, the CRISPR system 
offers a simpler means of achieving specificity (a guide RNA rather than a DNA-binding protein 
domain that requires complex engineering), but also demonstrates equal or greater cleavage 
efficiency [111]. 
The most widely used method for studying gene function to date is RNA interference 
(RNAi). RNAi functions by delivery of short RNA molecules complementary to the messenger 
RNA (mRNA) produced by the target gene, resulting in its destruction. Despite its remarkable 
utility, RNAi does not provide the means to obtain absolute silencing of a gene. Furthermore, 
when evaluation of mutations within a gene is the goal, RNAi must be combined with 
overexpression of DNA containing the desired mutations, which results in fluctuating expression 
conditions when compared with the endogenous gene. Newer genome editing methodologies are 
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allowing investigators to modify endogenous genes in a relatively easy manner. Clearly, these 
technologies will be the mainstay for evaluation of gene function in the near future. The CRISPR 
system in particular, is an efficient and reliable approach that at the same time offers ease of 
design and cheap costs [112]. Despite being a very recent technology, the CRISPR system has 
gained prominence during the last year [112]. More importantly, recent reports have 
demonstrated efficient editing of the human genome using CRISPR [113-117]. As an alternative 
approach to RNAi methodology, we decided to implement the use of CRISPR technology in the 
lab for analysis of genes involved in kinetochore function. As a proof of principle, I will 
fluorescently tag the endogenous kinetochore Hec1 gene in the non-cancer Retinal Pigment 
Epithelial cell line RPE1. Here, I describe the experimental design rationale and discuss the 
factors to be considered during the course of these experiments. The establishment of this 
technology in the lab will allow for knock-out and knock-in of genes in the cell lines commonly 
used for our analysis of kinetochore function.  
 
A2.2 CRISPR: Overview 
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system was 
first discovered in bacteria as a defense mechanism against foreign DNA, either viral or plasmid 
[112]. So far, three distinct bacterial CRISPR systems have been identified, termed type I, II and 
III. The Type II system is the basis for the current genome engineering technology available and 
is often simply referred to as CRISPR.  
The bacterial CRISPR locus contains the RNA-guided nuclease Cas9, Cas proteins 
involved in the generation of “spacer” sequences (fragments of the viral or invading DNA), a 
region of repeats and spacers from which a pre-crRNA is transcribed, and a tracRNA important 
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for processing of the crRNA-Cas9 complex that directs the double strand break on the target 
DNA (Figure A2.1) [112, 113]. Upon invasion, the Cas complex cleaves the foreign DNA 
generating spacers that are integrated in the CRISPR locus. Each spacer is localized between 
repeats present in the CRISPR locus. This region (sequence of repeat/spacer/repeat) is then 
transcribed, generating a long pre-crRNA. The pre-crRNA is recognized by the tracRNA, Cas9 
and RNAIII, resulting in cleavage within each spacer and generating mature crRNAs that remain 
associated with Cas9 and the tracRNA. Since this crRNA-tracRNA-Cas9 complex contains a 
portion of the foreign DNA or spacer, and Cas9 has nuclease activity, the complex is able to 
recognize a new molecule of the foreign DNA and induce cleavage in a selective manner (Figure 
A2.1) [112, 113]. Recently, it was demonstrated that a crRNA-tracRNA fusion (gRNA) together 
with Cas9 are functional in vivo (Figure A2.2) [113, 118, 119]. Importantly, Cas9 only mediates 
cleavage of the target if a protospacer adjacent motif (PAM) is present in the immediate 3’ 
region of the target (Figure A2.2). For the S. thermophilus system, Cas9 cuts 3bp upstream of the 
protospacer [113, 118]. By using this CRISPR minimal system, different labs have been able to 
modify the genome of several organisms with relatively high efficiency [112]. Specifically, the 
Cas9 protein together with the gRNA containing the target region (spacer in the bacterial 
system), are ectopically expressed in cells to generate a DSB in the desired region. If a donor 
plasmid is also provided, homologous recombination is induced. Below, I describe the detailed 
procedure for CRISPR-mediated tagging of endogenous Hec1 in RPE1 cells.  
 
A2.3 Experimental Design 
Here, I aim to introduce the codifying region of the fluorescent protein Neon green [120] 
at the C-terminus of the last exon of the Hec1 gene in the genome of the mammalian cell line 
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RPE-1. For this purpose I will introduce a DNA DSB in the last exon of Hec1 (the potential 
break site depends on the bioinformatics analysis for search of the guide RNA in this region). 
This break will be achieved by transfecting cells with a bicistronic vector that expresses codon-
humanized Cas9 nuclease, together with a Hec1-specific crRNA-tracRNA chimera (guideRNA) 
[121]. In parallel, I will introduce a donor plasmid to serve as a template to repair the induced 
DSB. I designed two different donor plasmids, one aimed to introduce Neon green (pNeon-
Hec1), and another one aimed to introduce Neon green and a Puromycin cassette (pNeon-Hec1 
Puro) containing flanking LoxP sites for removal after selection. Cells expressing Neon green 
upon transfection with pNeon-Hec1 will be selected by Fluorescence Activated Cell-Sorting 
(FACS), while cells expressing Neon green upon transfection with pNeon-Hec1 Puro will be 
selected by their resistance to treatment with Puromycin. Recent studies have demonstrated that a 
version of the dimeric nuclease Cas9, in which one of its nuclease domains is mutated and 
rendered inactive, is able to produce a single-strand DNA break (nick) [114, 122]. This nickase 
Cas9 has been reported as an alternative for genome editing with less off-target effects than a 
wild-type Cas9 [114, 122]. Thus, I will use both wild-type Cas9 and nickase Cas9, in parallel 
experiments, to compare efficiency and resulting phenotypes possibly caused by off-target 
effects. Table A.2.1 summarizes the four experiments described. 
 
A2.4 Experimental procedure 
1. Genomic sequence analysis: 
1.1. Go to the webpage http://genome.ucsc.edu/ and go to Genome Browser. 
1.2. Type the name of your gene of interest. An assembly map will appear, containing the 
different transcript variants for this gene. 
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1.3. Click on the correct transcript variant for the gene. For example, make sure that the variant 
you choose contains the right number of exons and it gives the right size of the protein. A 
description for the gene and transcript variant will appear.  
1.4. At the bottom of the description of the gene you will find a box with links to tools and 
databases. Click on the option “Genomic sequence”. A window called “Get Genomic 
Sequence Near Gene” will appear. 
1.5. Choose to retrieve 1000 bp upstream and downstream, UTR in lower case, and the sequence 
in FASTA mode. 
1.6. Paste the retrieved sequence in a DNA sequence analyzer. For all analysis shown in this 
document, I used Geneious v5.0.4.  
1.7. In Genome browser, go back to the description page for the gene and copy the RefSeq 
summary number. This is the annotation number in GeneBank (NCBI).  
1.8. Go to NCBI and search for the RefSeq number. You will have the mRNA sequence of your 
gene, with the annotations for all exons. Transfer this information to your sequence analyzer 
software. Alternatively, identify the exons and introns only in the region in which you want 
to modify your endogenous gene. For example, I want to introduce the fluorescence protein 
Neon Green at the C-terminus of the last Exon of Hec1, therefore, I need to be familiar with 
all the features around that region, introns, exons, 3’UTR, and polyadenylation region, if 
possible.  
1.9. With both sequences, the one obtained from NCBI and the one from Genome Browser 
UCSC, you now have the sequence for your entire gene and 1000bp upstream and 
downstream of your gene. In addition, you know all the features of your gene required to 
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design your donor plasmid and your guide RNA plasmid. See Figure A2.3 as an example of 
the architecture of the CASC5 gene (KNL1 protein).  
 
2. guideRNA design and cloning: 
2.1. Go to the webpage http://crispr.mit.edu/ and paste 250nt DNA sequence of the region of 
your gene in which you aim to induce the DSB or nick and submit your query. 
2.2. In the results webpage, look for the guide RNA sequence with highest score (listed as guide 
RNA #1) and copy the information related to this guide RNA in an excel document. Make 
sure you save the list of potential off-target sites for this guide RNA for future reference. 
2.3. Go to your sequence analyzer, find this sequence and make its annotation in your genomic 
sequence. Importantly, the guide RNA sequence found here contains the PAM sequence (last 
3 nucleotides), but the PAM sequence is NOT cloned into the Cas9-gRNA chimera vector 
(Figure A2.4). 
2.4. Design the oligos (primers) for cloning of the guide RNA (without PAM sequence) into the 
vectors pX330 and pX335 (Figure A2.4). Specifically, oligo 1: 5’-CAACG-(19-25N)-3’ and 
oligo 2: 5’-AAAC-(19-25N)-C-3’ (Figure A2.4). The guide RNA needs to initiate with a G 
(bold base in oligo sequence) in order to be transcribed by the U6 promoter. If your guide 
RNA does not start with a G, this G base can be added. 
2.5. The cloning protocol for the guide RNA (gRNA) into pX330 and pX335 can found here: 
http://www.addgene.org/static/cms/files/CRISPR_cloning_protocol.pdf. Briefly: 
a) Digest 1-2ug of pX330/pX335 with BbsI for 30min at 37C 
b) Gel purify digested pX330/pX335 
c) Phosphorylate and anneal oligos 1 and 2: 
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1uL oligo 1 (100uM) 
1ul oligo 2 (100uM) 
1ul 10X T4 ligation buffer (NEB) 
6.5ul ddH2O 
0.5ul T4 PNK (NEB) 
In a thermocycler: 37C for 30min/95C for 5min/down to 25C at 5C/min. 
d) Ligate phosphorylated and annealed oligo-duplex with pX330/pX335 using quick ligase 
(NEB). Use 1:250 dilutions of oligo-duplex.  
e) Treat ligation reaction with PlasmidSafe exonuclease. 
f) Transform ligation in E coli, miniprep and sequence. 
  
3. Donor plasmid (homologous repair template) design and cloning 
Cloning of the donor plasmid can be performed in several ways, including regular cloning. Based 
on information found on the Bob Goldstein lab webpage 
(http://wormcas9hr.weebly.com/uploads/1/0/6/5/10652065/cloning.pdf), Gibson assembly PCR 
is the easiest approach for cloning of these large constructs. The cloning protocol described here 
is based on the Gibson assembly system (New England Biolabs). 
3.1. Design primers to amplify around 1500-2000bp downstream and upstream of the gRNA 
(Figure A2.5A). 
3.2. Amplify the genomic fragment with primers designed in 3.1. Gel purify the amplified 
genomic PCR and use it as a template to amplify the different cassettes required for Gibson 
assembly (Figure A2.5B-D). 
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a)  In order to carry out the Gibson assembly approach, the primers need to be designed in a 
way that they overlap at least 30bp (Figure A2.6). In addition, I designed the forward 
primer amplifying the left homology arm and the reverse primer amplifying the right 
homology arm, containing “tails” for in-fusion cloning (Clontech), a ligation independent 
cloning system.  
3.3. Carry out PCR to obtain the different fragments required for assembly (Figure A2.5D), gel 
purify them, and carry out Gibson Assembly. Specifically: 
a) Mix ~200-300ng of each PCR product. If the fragment is <200bp use ~500ng. 
b) Combine the PCR fragment mix with 2X Gibson assembly master mix and incubate at 
50C for 60min in a thermocycler. 
3.4. Carry out the in-fusion reaction using the product of Gibson assembly reaction with the 
linearized vector backbone. I digested pEGFP-N1 (clontech) with NdeI and NotI, resulting in 
a linearized plasmid lacking the GFP coding region and a disrupted CMV promoter. 
3.5. Transform the in-fusion reaction in E coli, miniprep and sequence.  
3.6. Maps of both donor plasmids, pNeon-Hec1 and pNeon-Hec1 Puro are shown in Figures 
A2.7 and A2.8.  
 
A2.5 Future Experiments 
Transfection of RPE1 cells will be carried out using Fugene or nucleofection to compare 
transfection efficiencies. Also, different amounts and ratios of Hec1 gRNA and Hec1 donor 
plasmids will be examined. As controls, combinations of empty gRNAs (pX330 and pX335) 
with Hec1 donor plasmids and Hec1 gRNAs with empty donor plasmids (pNeon) will be used. 
Targeting efficiency will be evaluated by comparing the percentage of Neon green expressing 
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cells in experiments carried out with pNeon-Hec1 (without Puromycin selection), or, by the 
number of foci obtained after Puromycin selection in experiments carried out with pNeon-Hec1 
Puro. Selection of individual cells will be carried out by FACS or by single-cell serial dilution. 
Figure A2.1. Representation of the molecular mechanism of CRISPR in bacterial cells. Adapted
from Mali et al. 2013 [122].
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Figure A2.2. Representation of the complex formed between Cas9 nuclease and the chimera
tracRNA-crRNA (guide RNA), recognizing the protospacer or endogenous DNA sequence and PAM
sequence for subsequent cleavage. Adapted from Mali et al. 2013 [122].
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Donor Plasmid Nuclease type Purpose
pNeon-Hec1 Wild type DSB in last exon of the Hec1 gene for insertion of Neon 
green fluorescent protein. Selection by FACS.
pNeon-Hec1 Nickase Single strand break in last exon of the Hec1 gene for insertion 
of Neon green fluorescent protein. Selection by FACS.
pNeon-Hec1 Puro Wild type DSB in last exon of the Hec1 gene for insertion of Neon 
green fluorescent protein and a Puromycin cassette. Selection 
by resistance to Puromycin.
pNeon-Hec1 Puro Nickase Single strand break in last exon of the Hec1 gene for insertion 
of Neon green fluorescent protein and a Puromycin cassette. 
Selection by resistance to Puromycin.
Table A2.1. List of experiments designed for CRISPR-mediated fluorescent tagging of
endogenous Hec1. The combination of donor plasmid and type of nuclease are indicated. pNeon-Hec1
Puro contains LoxP sites for removal after selection with Cre recombinase.
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KNL1 gene architecture
Figure A2.3. Architecture of the human KNL1 gene as an example of an annotated genomic
sequence.
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Figure A2.5. PCR fragments for Gibson Assembly cloning. (A) primer design for PCR of genomic
Hec1 fragment from RPE-1 genomic DNA. (B) Amplification by PCR of a Hec1 genomic region
using primers designed in (A). (C) Amplification by PCR of the Neon green coding region and the
Puromycin cassette. (D) PCR fragments for Gibson assembly (see Figure A2.6). PCR fragments 1, 2,
3, and 4a were used for cloning of pNeon Hec1 donor plasmid; PCR fragments 1, 2, 3, 4b, 5, and 6





































Figure A2.6. Primer design for Gibson Assembly. PCR fragments for cloning of pNeon-Hec1 Puro
donor plasmid are indicated (see Figure A2.6). PCR product 1= left homology arm (HAL); PCR
product 2= fragment of HAL containing the PAM sequence (the PAM sequence is mutated via primer
design to avoid cleavage of the donor plasmid by the gRNA-chimera nuclease once transfected in
cells); PCR product 3= Neon green coding region tagging inserted after and in-frame with last Hec1
exon (stop codon is inserted after Neon green coding sequence); PCR product 4b= ~300nt of 3’UTR
endogenous Hec1 sequence inserted after Neon green coding region for mRNA processing of the
Hec1-Neon green transcript in cells; PCR product 5= Puromycin cassette containing a PGK promoter,
the PURO coding sequence and a bGH polyadenylation site (pA) (LoxP sites are inserted before and
after Puro cassette for removal of the cassette after Cre recombinase expression); PCR product 6= right
homology arm (HAR). Overlapping regions between PCR fragments, required for Gibson Assembly
cloning, are indicated in blue.
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Figure A2.7. Map of Hec1 donor plasmid pNeon Hec1. HAL indicates left homology arm; HAR
indicates right homology arm; NeonG-N and NeonG-C indicate the location of designed primers for
sequencing upstream and downstream of the Neon Green coding region. pEGFP-C2 REV indicates
location of designed primer for sequencing upstream NotI restriction site.
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Figure A2.8. Map of Hec1 donor plasmid pNeon Hec1. HAL indicates left homology arm; 3’UTR
indicates ~300nt of 3’UTR endogenous Hec1 sequence inserted after Neon green coding region and
stop codon for mRNA processing; PGK promoter, PURO and bGH pA indicate the Puro cassette
inserted for selection; HAR indicates right homology arm; LoxP sites are indicated; pEGFP-C2 REV




LIST OF ABREVIATIONS  
 
ABK: Aurora B Kinase 
APC/C: Anaphase Promoting Complex/Cyclosome 
Bub1: Budding Uninhibited by Benzimidazoles 1 
Bub3: Budding Uninhibited by Benzimidazoles 3 
BubR1: Budding Uninhibited by Benzimidazoles 1 homolog Beta (Bub1B) 
CASC5: Cancer Susceptibility Candidate 5 
CCAN (Constitutive Centromere Associated Network) 
Cdc20: Cell-division cycle protein 20  
CMV: Cytomegalovirus 
CPC: Chromosomal Passenger Complex 
CRISPR: clustered regularly interspaced short palindromic repeats  
DSB: Double Strand Break 
FACS: Fluorescence-activated cell sorting 
gRNA: guide RNA 
H2A: Histone H2A 
HDR:  homology-directed repair 
Hec1: Highly Express in Cancer 
HP1: Heterochromatin Protein 1 
INCENP: Inner Centromeric Protein 
KMN: KNL1-Mis12-Ndc80  
KNL1: Kinetochore Null 1 
Mad1: Mitotic Arrest Deficient 1 
Mad2: Mitotic Arrest Deficient 2 
Mis12: Minichromosome Instability 12-like protein 
Mps1: Monopolar Spindle 1 
mRNA: messenger RNA 
MS: Mass Spectrometry 
MT: Microtubule 




NHEJ:  non-homologous end-joining 
PAM: protospacer adjacent motif 
PP1: Protein Phosphatase 1 
PP2A: Protein Phosphatase 2A 
RNAi: RNA interference 
RZZ: Rod-Zw10-Zwilch 
SAC: Spindle Assembly Checkpoint 
TALENs: transcription activator-like effector nucleases 
TPR: tetratricopeptide repeat 
ZFN: Zinc Finger Nuclease 
Zw10: Zeste white 10 
Zwint1: Zw10 interacting protein 1 
 
